UICC Annual Report 2007: Uniting to defeat cancer

Uniting to defeat cancerAnnual Report

2007

International Union Against CancerUnion Internationale Contre le Cancer

Franco Cavalli, President(Switzerland) David Hill, President-elect(Australia) John R Seffrin, Immediate pastpresident (USA)Farhat Ben Ayed (Tunisia) Eduardo Cazap (Argentina) Mary Gospodarowicz (Canada) Xishan Hao (China) Ranjit Kaur (Malaysia) Tomoyuki Kitagawa (Japan) Arun Kurkure (India) Alex Markham (UK) H Fred Mickelson (USA) Pearl Moore (USA) Thierry Philip (France) Harri Vertio (Finland) Roberto Zanetti (Italy) Miri Ziv (Israel)

UICC has made every effort to ensure all information contained in this annual report is accurate and cannot be held responsible for any inadvertent errors that may have occurred

Editorial: Páraic RéamonnDesign and layout: Carlos Ocampo

Executive directorIsabel Mortara

Deputy executive directorJuerg Boller

Director's officeBrita BakerAna OliveraEvelyn Zuberbühler

International cancer fellowshipsBeate VoughtRaluca GrigorescuKaren Silverman

GLOBALinkWayne KaoHarold Colomes

Health-care coordinationSilvia Perel-LevinClaudia DurgnatVictoria KayElla NkanaguAnna-Maria Vandelli

Campaigns and communicationsAline IngwersenPáraic RéamonnAlfonso GomezCarlos Ocampo

ConferencesLaurence VerhagenClaire ChombeauNeil Kirkman

Finance and administrationJuerg BollerJeannette NyandwiMarion OvidePhilomène Taylor

MembershipAlina PawlowskaItalo GoyzuetaAnnie Imhof

Information technologyHarold ColomesFrançois CardinauxDiego Mirner

Secretariat

Strategic leadersJeff Dunn (Australia)Joe Harford (USA)Luk Joossens (Belgium)Hélène Sancho-Garnier (France)Kazuo Tajima (Japan)

Editor-in-chief, InternationalJournal of CancerHarald zur Hausen (Germany)

Executive directorIsabel Mortara (Switzerland)

Board of directors

The board of directors in Washington DC in July 2006

Tabl

eof

cont

ents

The International Union Against Cancer(UICC) is the leading non-governmentalorganization dedicated to global cancer

control. Founded in 1933, it is an independentassociation of over 300 member organizationsin more than 100 countries. UICC is non-profit,non-political and non-sectarian. It creates andcarries out programmes around the world incollaboration with hundreds of volunteerexperts, working in four strategic directions:cancer prevention and control, tobacco control,knowledge transfer, and capacity building andsupportive care. Particular emphasis is placed onprofessional and public education.

VisionUICC’s vision is of a world where cancer is

eliminated as a major life-threatening diseasefor future generations.Mission

UICC’s mission is to build and lead the globalcancer control community engaged in sharingand exchanging cancer control knowledge andcompetence equitably, transferring scientific find-ings to clinical settings, systematically reducingand eventually eliminating disparities in preven-tion, early detection, treatment and care of can-cers, and delivering the best possible care topeople living with cancer throughout the world.

About UICC

Table of contentsFrom the president and the executive director . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2Cancer conferences in 2007 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3Milestones . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4Cancer conferences in 2008 and beyond . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5Towards true cancer control . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7Uniting to control tobacco . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13Transforming knowledge into action . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17Building capacity and supporting patients . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23Member organizations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28David Hill, president-elect . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30Committees and taskforces . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31International cancer fellows 2007 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34Financial report . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36Letter from PricewaterhouseCoopers SA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38Balance sheet . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39Contributors 2007. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40

1

Uniting to defeat cancer

From the president and theexecutive director

Isabel MortaraUICC executive director

Dr Franco CavalliUICC president

UICC Annual Report 2007

2

We wrote these words inGlobal Action againstCancer, a booklet we first

co-published with the World HealthOrganization in 2003. Even earlier,the Charter of Paris adopted on 4February 2000 called for “an invin-cible alliance - between researchers,health-care professionals, patients,government, industry and the media- to fight cancer and its greatestallies, which are fear, ignorance andcomplacency”.

Today, we know more than everbefore about how to prevent andcure cancer. Yet cancer is still nothigh enough on public and politicalagendas.

We know the challenge we face.Cancer killed almost 8 million peo-ple in 2007 - about one in eight ofall deaths.

If we do nothing, deaths from can-cer worldwide will soar to an esti-mated 12 million deaths in 2030.

New cases of cancer are expectedto jump from over 11 million toalmost 16 million in the sameperiod.

Eighty percent of cancer deathsoccur in low- and middle-incomecountries, as a consequence of unac-ceptable global inequities in healthsystems for cancer prevention, earlydetection, treatment and care.

Human tragedy on this scaledemands a decisive response.

If we act today, we can make a realdifference for tomorrow.

This annual report outlines a year ofprogress, victories, setbacks andinnovation. UICC has made everyeffort to put cancer on public anddonor agendas, transfer knowledgefrom those who have it to thosewho don't, and build local capacityparticularly in low- and middle-income countries, where cancerpresents a growing challenge topublic health.

We work in partnership with ourmember organizations – now over300 in more than 100 countries –and other stakeholders such as theWorld Health Organization(WHO), the International Agencyfor Research on Cancer (IARC),and the International Atomic

“We've tried working alone, and we've had limitedsuccess. Now is the time for a new approach – allsectors, public and private, working together toachieve a common goal – the control of cancer.”


UICC's calendar of international cancer conferences listsmajor international cancer-related conferences, meetingsand congresses over three years and is available in print and

at www.uicc.org. In 2007, 18,000 copies of the printed version weredistributed, thanks to funding from Pfizer Oncology.

Trivandrum Breast Conference 2007Trivandrum, India, 23-25 February2nd National Cancer Patient ForumAnkara, Turkey, 6-7 AprilInnovation and clinical practice: Anti-cancer summit 2007Shanghai, China, 17-19 AprilAsia and cancer management in the 21st centurySuntec, Singapore, 21-22 April32nd Oncology Nursing Society annual congressLas Vegas, Nevada, USA, 24-27 April14th Reach to Recovery International breast cancer support conferenceStockholm, Sweden, 30 May-2 JuneAll Russian National Forum: Health or TobaccoSt Petersburg, Russia, 28-31 MayStop cervical cancer in Latin America, Buenos Aires, Argentina, 19-20 JuneCurrent Trends in Oncology. International Oncology ConferencePune, India, 24-26 August1st Global Insight Conference on LeukaemiaMumbai, India, 10-11 SeptemberAdvance in Cancer Research and Drug Discovery: World Cancer ConferenceBeijing, China, 13-15 September4th Congress of South Caucasian Oncologists and RadiologistsTbilisi, Georgia, 27-28 September4th European Conference on Tobacco or HealthBasel, Switzerland, 11-13 OctoberAORTIC 2007. Cancer in Africa: Challenges and opportunitiesCape Town, South Africa, 24-28 OctoberONS 8th Annual Institutes of LearningChicago, Illinois, USA, 9-11 November19th Asia Pacific Cancer Conference and 1st APCC nursing meetingTehran, Iran, 15-17 November2nd International Cancer Control ConferenceRio de Janeiro, Brazil, 25-28 November

3

Energy Agency (IAEA). We couldnot achieve all we do without theaid of hundreds of voluntaryexperts, decision-makers, caregiversand patient groups who give oftheir time, energy and dedicationto further our vision of a worldwhere cancer is no longer a majorlife-threatening disease for futuregenerations.

Together, we have opened doors toensure that prevention, effectivetreatment and supportive care aremore accessible. Yet there is still somuch more that we must do.

The new World CancerDeclaration to be presented to theWorld Cancer Congress in 2008sets forth ambitious targets to maketrue cancer control a global realityby 2020 and provides a frameworkfor common action.

United, we can defeat cancer.

Dr Franco CavalliUICC president

Isabel MortaraUICC executive director

From

the

pres

iden

tan

dth

eex

ecut

ive

dire

ctor

!C

ance

r co

nfer

ence

s in

200

7

Cancer conferences in 2007

Milestones


4

JanuaryOn 8 January, the National CancerInstitute (INCA) in France begins anew communication programmethat celebrates “two million ordinaryheroes” - men and women inFrance who are living with canceror have had a cancer experience.The aim is to change public percep-tion of the disease. In Ankara,Hacettepe Hope Lodge welcomes itsfirst guests.

FebruaryOn World Cancer Day (4 February),UICC launches “Today’s children,tomorrow’s world”, a five-year can-cer prevention campaign focused onchildren and their parents. TheInternational Agency for Researchon Cancer publishes new cancerestimates for Europe, updated from2004. The US Institute of Medicinepublishes Cancer Control Opportunitiesin Low- and Middle-income Countries.

MarchThe Pan-American HealthOrganization celebrates InternationalWomen’s Day with a focus on cer-vical cancer. The International BrainTumour Alliance announces a walkaround the world and sets anOctober date for an internationalbrain tumour awareness week. InParis, UICC signs the charter of aninternational network for cancercooperation, working in particularin countries that speak French.

AprilThe UICC board of directors adoptsa position paper on cervical cancerand HPV vaccination. The Lancet’sfirst forum on cancer managementin Asia draws together over 400 lea-ding cancer experts, researchers, and

policymakers in a bid to tackle thegrowing cancer burden in theregion. On the World Day forSafety and Health at Work (28April), the World HealthOrganization (WHO) says thecontrol of carcinogens in the work-place should be a key component ofevery national cancer control pro-gramme. In Buenos Aires, theInternational Agency for AtomicEnergy holds a special LatinAmerican event for its programmeof action for cancer therapy(PACT).

MayWHO unveils its global plan ofaction on cancer. UICC takes partin the London conference on cancercontrol in Africa. UICC’s TNMcore committee recommends adop-tion of new proposals for lung can-cer staging from the InternationalAssociation for the Study of LungCancer. Moscow hosts a forum onhealth or tobacco. Queen Silvia ofSweden speaks at the opening cere-mony of the 14th Reach toRecovery International breast cancersupport conference in Stockholm. Aconference in Brussels concludeswith the signing of a declaration forthe prevention of colon canceracross Europe. The Global Smoke-free Partnership publishes GlobalVoices for a Smoke-free World, a statusreport on the rapidly advancingmovement towards a smoke-freefuture.

JuneFinland goes smoke-free, banningsmoking in all workplaces, includingbars, pubs and restaurants withoutexception. WHO publishes the firstever country-by-country analysis of

the impact of environmental factorson health, revealing that 13 milliondeaths worldwide could be preven-ted every year by improving envi-ronments. The World Bankpublishes a report on public policyand the challenge of chronic non-communicable diseases.

JulyMeeting in Bangkok, the conferenceof the parties to the FrameworkConvention on Tobacco Controlagrees unanimously to begin nego-tiating a protocol on illicit trade oftobacco products and adopts guide-lines that stipulate 100% smoke-freepublic places and workplaces. TheNational Cancer Institute hosts asummit on how trans-disiplinarypartnerships can help eliminate can-cer health disparities across the US.President Levy Patrick Mwanawasaopens Zambia's first specialized can-cer treatment and radiotherapy cen-tre in Lusaka. The first “StopCervical Cancer in Africa:Accelerating access to HPV vac-cines” conference, held in Abuja,Nigeria, backs the global call to stopcervical cancer.

AugustThe Lancet reports a major cluster-randomized trial in Tamil Nadu,India, showing that screening byvisual inspection with acetic acid(VIA) is effective in reducing inci-dence and mortality from cervicalcancer. The first meeting of theTanzanian cancer control steeringcommittee, responsible for develo-ping the country’s national cancercontrol strategy, takes place in theOcean Road Cancer Institute, Dares Salaam.


Cancer 2008: 6th international cancer conferenceDublin, Ireland, 7-9 May 2008

Oncology Nursing Society Annual CongressPhiladelphia, Pennsylvania, USA, 15-18 May 2008

The Role and Involvement of the Patient's Family: Workshop on psycho-oncologyLarnaca, Cyprus, 30 May-1 June 2008

10th World Congress of Psycho-OncologyMadrid, Spain, 9-13 June 2008

cancer Biomedical Informatics Grid (caBIG): 5th annual meetingWashington DC, USA, 23-25 June 2008

World Cancer Congress 2008Geneva, Switzerland, 27-31 August 2008

Molecular Targets and Cancer Therapeutics: 20th EORTC-NCI-AACR symposiumGeneva, Switzerland, 21-24 October 2008

Molecular Markers in Cancer: NCI-ASCO-EORTC annual meetingHollywood, Florida, USA, 30 October-1 November 2008

Oncology Nursing Society Institutes of LearningSeattle, Washington, USA, 14-16 November 2008

10 Congreso Uruguayo de OncologíaMontevideo, Uruguay, 20-22 November 2008

ICTR 2009: 4th international conference on translationalresearch and pre-clinical strategies in radiation oncologyGeneva, Switzerland, 11-13 March 2009

15th UICC Reach to Recovery International breast cancer support conferenceBrisbane, Australia, 13-15 May 2009

For more information: visit www.uicc.org/calendar

5

SeptemberUICC announces “I love mysmoke-free childhood”, the firstfull-year theme in its five-year can-cer prevention campaign. WHOand its partners call for increasedresearch to improve patient safety.UICC launches the Global CancerControl Community, an online net-work for cancer professionals andvolunteers. By the end of the year ithas over 1,000 members.

OctoberUICC helps launch the CervicalCancer Action alliance and joins thegoverning council. The WorldCancer Reseach Federation publishesits second expert report on food,nutrition, physical activity and pre-venting cancer. The 4th EuropeanConference on Tobacco or Healthmeets in Basel. UICC establishes itscancer capacity building fund andcalls for projects for projects frommember organizations in low- andmiddle-income countries. WHOreleases its first guide on planningpalliative care services for peopleliving with advanced cancer.

NovemberThe UICC board of directors adoptsa position paper on equity in access tocancer drugs. The 2nd InternationalCancer Control Congress meets inRio de Janeiro and creates a Latin-American Caribbean Alliance forCancer Control.

DecemberIARC publishes Cancer Incidence inFive Continents vol IX. UICC’s “Mychild matters” initiative selects 18 pro-jects for further funding. At the end ofthe year, UICC membership stands at286 organizations in 93 countries.

Cancer conferences in 2008 and beyond

Mile

ston

es !

Can

cer

conf

eren

ces

in 2

008

and

beyo

nd

6



7

The World Health Organizationunveiled a global plan ofaction on cancer at a techni-

cal briefing during the World HealthAssembly in May 2007. The planbrings together a wide range ofstrategies to prevent what is prevent-

able, cure what is curable, relievepain and improve quality of life, andmanage for success.

UICC president Dr Franco Cavallispoke at the briefing, welcoming theplan’s emphasis on national cancercontrol planning and its recognition of

the continuing need for advocacy. “Inthe next 10 years every country shouldhave a national plan,” he said.

“Civil society and governmentsneed to work together closely to makethis happen.”

Towards true cancer control! Increase the number of countries with national cancer control programmes! Increase the number of countries with viable and adequately funded cancer surveillance

systems, including cancer registries! Develop a collaborative international plan for implementing HPV vaccination programmes

in low- and middle-income countries where the burden of cervical cancer is highWorld Cancer Declaration 2006

National cancer controlCancer organizations can playan important role in raisingpublic and leadership aware-ness of the cancer problem,developing effective partner-ships for cancer planning, andproviding technical support.UICC’s planning resourcesprovide practical suggestionsthat can be applied in anycontext, including countrieswith very limited resources. In 2007, UICC publishedFrench and Arabic versions ofthe resources, to go with theEnglish and Spanish editionsalready available. Online toolsin English, French and Spanishfor use with the resources willbe published in 2008.

Tow

ards

tru

e ca

ncer

con

trol

Cancer causes and outcomes inlow- and middle-income countries(LMCs) differ from those in the devel-oped world, and cancer is generallylow or absent on the health agenda ofthese countries, even though theirshare of the disease burden is growing.

Cancer Control Opportunities in Low-and Middle-Income Countries, a reportfrom the US Institute of Medicinepublished for World Cancer Day2007, rejects a “one-size-fits-all”response. Each country should decideon a national cancer control plan thattakes into account its own prioritiesand goals, adopting targeted, resource-appropriate cancer control strategies.

The most effective approach tocontrolling cancer is to prevent itoccurring, and the report identifiesseveral practical measures – above all,ratifying and implementing theFramework Convention on TobaccoControl.

“Resource-level-appropriate guide-lines” similar to those from the BreastHealth Global Initiative should bedeveloped for other cancers, the reportsays. It also recommends that LMCsdevelop centres of excellence to serveas focal points in fighting cancer.

Cancer can be extremely painful,particularly for those with advancedand fatal disease. The report recom-mends that LMCs remove unnecessar-ily strict limits on morphine and otherstrong opioid painkillers – the onlydrugs that work.

Without reasonably accurate datacollected over time, it is impossible tounderstand the existing cancer burdenor gauge the effect of interventions.The report recommends that LMCsinstitute appropriate surveillance andmonitoring.

“It’s clear that cancer will becomean increasingly heavy burden on low-and middle-income countries,” saysDr Joe Harford of the US NationalCancer Institute, UICC’s strategicleader for knowledge transfer. “Nowis the time to address in earnest whatcan be done in these societies.”

To show what can be done, UICChas joined with PACT – the IAEA’sprogramme of action for cancertherapy – in demonstration projectsin three pilot countries: Nicaragua,Tanzania, and Vietnam. UICC isworking closely with our members inthese countries to ensure that theybenefit from the programme.

Cancer control opportunities in LMCs

The 2nd International CancerControl Congress, which met in Riode Janeiro in November 2007,underlined the need for a globalcommunity of practice where we canall benefit from each other’s experi-ence and wisdom.

Cancer is the second cause of deathin Latin America and the Caribbean.People on lower incomes are most atrisk and have consistently worse sur-vival rates. As populations in the

region age, cancer incidence is set torise sharply.

Dr Luiz Antonio Santini, director-general of the National CancerInstitute of Brazil (INCA), chairedthe congress. Under his leadership,participants initiated a LatinAmerican-Caribbean Alliance forCancer Control. The aim is to har-

ness energies, create synergies andorganize regional collaboration. Thealliance will be coordinated by thePan-American Health Organization(PAHO) and developed in concertwith UICC, the World HealthOrganization (WHO), and otherleading agencies.

8


In December, the InternationalAgency for Research on Cancer(IARC) published the ninth volumein the series Cancer Incidence in FiveContinents. This series, started byUICC in the 1960s, is the recognizedreference source on the incidence ofcancer around the world, providinghigh-quality incidence data for dif-ferent populations.

The ninth volume, produced in col-laboration with the InternationalAssociation of Cancer Registries, basesits information on 12 million cancercases from 300 populations in 60 coun-tries, representing 11% of the world’spopulation. This shows how far cancerregistration has come since the 1960sand also how far there is still to go.

“The value of a cancer registrydepends on the quality of itsdata and the extent to whichthey are used in research andhealth services planning.Epidemiological research,based on comprehensive can-cer registration, is the mostvalid and efficient way to planand evaluate all aspects ofcancer control.”

Eva Steliarova-Foucher,International Agency for

Research on Cancer

In March, UICC signed a charterin Paris setting out the objectives,organization and modus operandi ofan international network for cancercooperation. Other signatories werethe French ministries of foreign

affairs and for health and solidarity,the French National Cancer Institute(INCa), the National League AgainstCancer, Cancérologues sans fron-tières, Physiciens médical sans fron-tières, and the Alliance mondiale

contre le cancer. The network will promote the

development of global strategies andprogrammes of action, in particular inthe 42 countries where French is thelanguage of communication.

Cancer incidence in five continents

A new alliance in Latin America

France promotes international cooperation on cancer

Dr Luiz Antonio Santini


In October, UICC joined withother civil society and public healthorganizations in Cervical CancerAction (CCA), a new alliance todemand universal access to new life-saving cervical cancer vaccines,screening tools, and treatment.

The origins of the alliance go backto the Stop Cervical Cancer roundtable convened by UICC and four

partners in London inDecember 2006. This led inJune 2007 to a global call to stopcervical cancer, which spoke of“a historic opportunity” toreduce the burden of cervicalcancer around the world,improve reproductive health,and save millions of women’slives.

The global call recognizes that onlya comprehensive strategy, combiningvaccination with screening and treat-ment programmes, will reverse thethreat of cervical cancer. It acknowl-edges that extraordinary action willbe required to give women and girlseverywhere rapid access to suchpowerful new technologies as HPVvaccines and HPV testing.

Therefore, it calls on industry toprovide adequate supplies of the newtechnologies at radically tiered pricesand calls for committed action on thepart of governments, multilateralagencies, the international donorcommunity and development part-ners, health professionals, and civilsociety.

Cervical Cancer Action waslaunched in London at WomenDeliver, a global conference on sav-ing the lives and improving thehealth of women, mothers and new-born babies.

“It is a moral imperative to ensurethat access to new life-saving tech-nologies follow the burden of the dis-ease, not wealth,” said MaryRobinson, the former president of

9

Tow

ards

tru

e ca

ncer

con

trol

The rapidly changing landscape ofcervical cancer prevention and earlydetection demands the developmentof comprehensive, effective andappropriate strategies.

Cervical cancer is the secondlargest cause of death from cancer inwomen worldwide. For women inlow- and middle-income countries, itis the biggest cancer killer. Nearly300,000 women die each year fromcervical cancer – 85% of them indeveloping countries.

Thirty years after Dr Harald zurHausen showed that cervical cancer iscaused by infection with the humanpapilloma virus (HPV), vaccines toprevent infection are becoming avail-able.

In industrialized countries, expand-ed screening and treatment have dra-matically reduced cervical cancer

rates over the last 60 years. But indeveloping countries, where morethan 95% of women never have a papsmear, the death rate from cervicalcancer continues to rise.

Recognizing that the new HPVvaccines have the potential to preventcervical cancer on a large scale, theWorld Cancer Declaration 2006included HPV vaccination in devel-oping countries among its prioritysteps. The declaration acknowledgedthat vaccination programmes must bebased on what is affordable, feasible,and culturally acceptable in eachcountry and vaccination does notremove the need for screening.

UICC subsequently developed acomprehensive approach to cervicalcancer prevention and control in twoposition papers approved by theboard of directors.

Dr Harald zur Hausen, who pioneeredresearch into cervical cancer and HPVinfection, heads the UICC initiative

Dr Kazuo Tajima, UICC strategicleader for cancer prevention and con-trol, chaired a symposium inNovember on future directions forcancer control in Asia. The sympo-sium, held during the 19th AsiaPacific Cancer Conference inTehran, was co-chaired by DrArdeshir Ghavamtzadeh, founder anddirector of Iran’s leading cancer insti-tute, the Haematology-Oncologyand Stem Cell Research Centre.

The symposium was a milestone inthe discussion between the Asian andPacific Federation of Organizationsfor Cancer Research and Control(APFOCC) and the Asian PacificOrganization for Cancer Prevention(APOCP), aimed at building a firmfoundation for cancer research andprevention across the region.

New directions in Asia?

UICC launches initiative on cervical cancer

UICC supports Cervical Cancer Action coalition

Dr

Kazu

o Ta

jima

Food, Nutrition, Physical Activity,and the Prevention of Cancer, the WorldCancer Research Fund’s secondexpert report published in October2007, is a comprehensive report onthe links between cancer and diet,physical activity and weight.

Its key finding is that maintaining ahealthy weight (a body mass index of20-25) is one of the most importantthings you can do to prevent cancer.Since the last WCRF report in 1997,the number of types of cancer wherethere is convincing evidence thatbody fat is a cause has risen from oneto six, including colorectal cancerand post-menopausal breast cancer.

Other recommendations include:• be physically active as part of

everyday life• limit consumption of energy-dense

foods and salt and avoid sugary drinks

• eat mostly foods of plant origin,but avoid mouldy cereals (grains)or pulses (legumes)

• avoid processed meat and limitintake of red meat

• limit alcoholic drinks• aim to meet nutritional needs

through diet alone, without relyingon dietary supplementsIn one of the first breastfeeding

recommendations made by a cancerprevention report, mothers areadvised to breastfeed exclusively forsix months and to continue withcomplementary breastfeeding afterthat. This is because of convincingevidence that breastfeeding protectsthe mother against breast cancer andprobable evidence that it protects thechild against obesity later in life.

People living with cancer or whohave recovered from the disease

should ordinarily follow these rec-ommendations, the report also says.

Ireland and UN high commissionerfor human rights, who chaired theconference.

UICC is represented on the CCAgoverning council alongside eightother organizations, including two ofits members: the American CancerSociety and Cancer Research UK.


10

Maintain a healthy body weight

“Today’s children, tomorrow’s world”

UICC backs European petition

Every year, more than 50,000women in Europe are diagnosed withcervical cancer and 25,000 womendie from it.

In July, UICC joined forces with theEuropean Cervical CancerAssociation (ECCA) – a new UICCmember – in an online petition call-ing on the European Union andnational governments to implementorganized programmes of cervicalcancer prevention uniformly across Europe and without delay. Theaim was to present signatures to the European commissioner forhealth during European Cervical Cancer Prevention Week, 20-26January 2008.

“Almost every case of cervical cancer in Europe could be prevent-ed through the equitable implementation of essential preventionprogrammes,” said UICC executive director Isabel Mortara.

The environment in which chil-dren grow up – at home, in school,and in the community – powerfullyinfluences their behaviour in laterlife. Simple changes in lifestyle canprevent about 30% of all cancer casesworldwide – well over three millioncases each year! Parents play an essen-tial role in promoting healthy habits.

On World Cancer Day, 4 February

2007, the International UnionAgainst Cancer launched “Today’schildren, tomorrow’s world”, thesecond phase in its World CancerCampaign.

Building on the success of its “Mychild matters” initiative (see page 27),UICC will work with its membersand partners in a five-year cancer pre-vention campaign that focuses in par-

ticular on children and their parents. The campaign will target parents,

teachers, health professionals anddecision-makers with four key mes-sages:• give children and young people a

smoke-free environment• encourage an energy-balanced

lifestyle based on healthy diet andphysical activity

Mary Robinson


• learn about vaccines against viruses thatcause some cancers (HBV and HPV vac-cines)

• teach children and teenagers to avoidUV exposure by being “sun-smart”Beginning in 2008, each of these mes-

sages will provide the theme for a yearlongcampaign.

President-elect Dr David Hill will lead atask force in developing a standard surveytool to help UICC members gauge publicunderstanding of and attitudes towardscancer prevention and risk reduction.

First results from this survey will be pre-sented at the World Cancer Congress in2008.

11

Tow

ards

tru

e ca

ncer

con

trol

“What we teach children nowwill shape their lives and willshape the world for decadesto come. This campaign isabout bringing awareness ofthings that seem so basic butreally are so important for thehealth of any child anywhere.Teaching children now waysto protect themselves fromcancer throughout their livesis such a simple yet wonder-fully life-affirming lesson forus to give as parents and asleaders.”

Steffi Graf, UICC goodwill ambassador

Every year, 40,000 people inMorocco are affected by cancer,including more than 1,000 chil-dren. When cancer strikes, thewhole family suffers. The poorare the most vulnerable, becauseof the high cost of health care.Prevention is one of the fouraims of the Lalla SalmaAssociation Against Cancer, aUICC member.

“One does not become invol-ved in fighting this diseasejust because it is the sensiblething to do,” Princess LallaSalma says. “It reflects a deepcommitment to change theway society sees cancer andbring together those whowant to give comprehensive,equitable and expert answersto those who are suffering. Foreach of us, this noble causecan turn into an exceptionalact of humanity and sharedhope.”

Princess Lalla Salma ofMorocco, UICC ambassador

World Cancer Day in 2007 was aneven bigger success than 2006, withmore media coverage and moreorganizations in every region takingpart.

Among UICC members, Australiatook the lead, with the CancerCouncil Australia, its eight state andterritory organizations, and the PeterMacCallum Cancer Centre all sched-uling events. “World Cancer Dayhelped us get coverage here wewould otherwise not have,” reportsUICC president-elect Dr David Hillfrom Cancer Council Victoria.

The prize for persistence goes tothe Indonesian Cancer Foundation,which went ahead with an interac-tive dialogue and media gatheringdespite major flooding in Jakarta.

“World Cancer Day is a good wayto get coordinated publicity on can-cer issues,” says Satu Lipponen of theCancer Society of Finland, whoworked closely with Finnish TV.

From Washington to Wellington,news media in every region coveredthe launch of “Today’s children,tomorrow’s world”. Our key mes-sages reached a diverse global audi-ence in more than two dozen lan-guages. CNN and China CentralTelevision reported on healthy habitsparents can share with children tohelp prevent cancer later in life.

WHO put out an official statementin support of World Cancer Day,attracting major interest from theUN press corps. The IAEA issued ajoint press release with UICC.

Second World Cancer Dayimproves on first


12

www.stop-tabac.ch www.prevention.ch

Smok

e-fr

ee in

side:

For

Wor

ld N

o To

bacc

o D

ay 2

007,

UIC

C jo

ined

for

ces

with

WH

O a

nd lo

cal

toba

cco

cont

rol o

rgan

izat

ions

in a

pos

ter

cam

paig

n fo

r sm

oke-

free

pub

lic p

lace

s in

Gen

eva.

One

yea

r la

ter,

the

Swiss

can

ton

wen

t sm

oke-

free


At the 56th World HealthAssembly in 2003, WHO’s192 member states unani-

mously adopted the first public healthtreaty, the Framework Conventionon Tobacco Control (FCTC), tostrengthen international actionagainst tobacco. Since it entered intoforce in February 2005, the conven-tion has become one of the mostwidely embraced treaties in UN his-tory. By the end of 2007, it had beensigned by 168 countries and ratifiedby 152 countries.

UICC was an active observer inthe second session of the conferenceof the parties to the FCTC, held inBangkok at the end of June. Two

key items on the agenda were a pro-tocol on illicit trade in tobacco pro-ducts and guidelines on protectingpeople from exposure to tobaccosmoke.

The Framework ConventionAlliance estimates that the illicit tradein cigarettes represents 10.7% ofglobal sales, or 600 billion cigarettesannually. Losses to government reve-nue as a result of the illicit tobaccotrade come to between US$40 and50 billion each year.

Article 15 of the FCTC obligescountries to take steps to eliminatethis illegal trade. This requires a pro-tocol on a comprehensive system ofinternational cooperation, including

obligations and measures addi-tional to those specified in thearticle. In one of several decisivemoves during the conference,the delegates agreed unani-mously to begin negotiations onthis protocol.

In another key resolution, theparties unanimously adoptedguidelines on protection fromexposure to environmentaltobacco smoke. The guidelinescall on national and localgovernments to enact lawsrequiring 100% smoke-freeworkplaces and public places.

The conference also resolvedto begin work on guidelinesrelated to packaging and label-ling of tobacco products andtobacco advertising, promotionand sponsorship and to streng-

then financial support for parties whoneed help to implement the conven-tion.

UICC welcomes the outcome ofthe Bangkok conference and willwork with its members and partnersto increase the number of countriesimplementing the strategies outlinedin the FCTC.

Uniting to control tobacco! Increase the number of countries implementing strategies that have been identified

as being successful in the WHO Framework Convention on Tobacco Control (FCTC)World Cancer Declaration 2006

13

Uni

ting

to c

ontr

ol t

obac

co

“The evidence is clear, there isno safe level of exposure tosecond-hand tobacco smoke.Many countries have alreadytaken action. I urge all coun-tries that have not yet done soto take this immediate andimportant step to protect thehealth of all by passing lawsrequiring all indoor work-places and public places to be100% smoke-free.”

Dr Margaret Chan, WHOdirector-general

In January 2007, the AmericanJournal of Public Health published ameta-analysis by the InternationalAgency for Research on Cancer thatdemonstrated a clear dose responsebetween exposure to second-handsmoke and lung cancer risk, showinga two-fold increased risk amonghighly exposed workers.

But the days of smoke-filled res-taurants and bars are a fadingmemory for many countries and willsoon be history worldwide, accor-ding to Global Voices for a Smoke-freeWorld, a report by the GlobalSmoke-free Partnership published forWorld No Tobacco Day.

UICC initiated and is one of theleading organizations in the GlobalSmoke-free Partnership, which pro-

motes effective smoke-free air policies world-wide.

The report finds thatas of 30 May 2007 morethan 200 million peoplewere already protectedby stringent laws, requi-ring smoke-free air in allenclosed workplaces,including all restaurants,bars and pubs.

Nine countries hadlaws that require smoke-free air in all workplaces,

including all restaurants, bars andpubs: Ireland, Uruguay, NewZealand, Bermuda, Iran, Scotland,Wales and Northern Ireland.England’s law took effect on 1 July.

Many other countries, includingFrance, Italy, South Africa and HongKong had laws covering most work-places. Some countries such asCanada, Argentina, Australia and theUnited States, had passed strongsmoke-free air laws at provincial,state, and city level.

The report predicts that with gro-wing ratification of the FCTC themomentum behind smoke-free airlaws will become unstoppable.

“The time for excuses and delay isover,” says Deborah Arnott, directorof Action on Smoking and Health inLondon. “The tobacco industry’sarguments for continuing to exposeworkers to second-hand smoke havebeen completely demolished scienti-fically, legally and politically.”


14

Towards a smoke-free world

This was the theme of the 4thEuropean Conference on Tobacco orHealth in Basel in October. Theconference, organized by the SwissCancer League in cooperation withthe Association of European CancerLeagues (ECL) and the GermanCancer Society and held under theauspices of UICC, looked at what hasbeen achieved and what still needs tobe done on the way to a tobacco-freeEurope.

Currently almost two-thirds ofEuropean countries have bans or res-trictions on smoking in most indoorpublic places, and some of these bansalso cover bars and restaurants.

Between 2002 and 2006, mostcountries in the region also madesignificant progress in banning adver-tising, increasing the size of healthwarnings, and strengthening product

regulation. In the European Union,the price of tobacco products rosebetween 2001 and 2005 by an annualaverage of 6.8% above the rate ofinflation. In some countries, howe-ver, notably in eastern Europe,tobacco became cheaper. Most coun-tries still do not earmark tobacco taxrevenue for tobacco control.

Tobacco remains the leadingcontributor to the disease burden inmost European states and alsoinvolves considerable economiccosts. Policy challenges remain inmany countries, particularly concer-ning restrictions on indirect adverti-sing, the introduction of smokingcessation programmes into nationalhealth-care systems and, above all,combating smuggling.

The European Tobacco ControlReport 2007 notes that smoking levels

in Europe have stabilized and in somecountries are decreasing, but urgesthat greater attention be given toyoung people (around 25% of 15-year-olds smoke every week),women and marginalized groups.

By strengthening controls in linewith the recommendations in theEuropean Strategy for TobaccoControl and the FCTC, Europeanstates could make a considerablecontribution to reducing the largehealth burden associated withtobacco consumption.

Towards a smoke-free Europe

Mob

ile p

ublic

ity v

an,

Dr

B Bo

rooa

h C

ance

r In

stitu

te, I

ndia


Russia has the third highest percapita cigarette consumption in theworld, low cigarette taxes and weaktobacco control legislation - enoughreasons to hold a forum on health ortobacco.

The forum, which met in Moscowat the end of May, was organized bythe State Duma in collaboration withUICC and other organizations. LukJoossens, UICC strategic leader fortobacco control, made a presentationon the anti-tobacco efforts of UICCand the Framework Convention

Alliance. Joe Harford, UICC strate-gic leader for knowledge transfer,spoke on the global fight against can-cer, with an emphasis on Russia andtobacco.

The driving force behind theconference was academician NikolaiGerasimenko, the deputy head of theDuma’s health-care committee.

The forum was widely reported inthe media and in June achieved itsfirst major success: the RussianFederation became a party to theFCTC.

15

Moscow hosts forum on health or tobacco

GLOBALink: the next stepsGLOBALink, the international

tobacco control online communityhosted by UICC since 1993, is arecognized platform for dialogue,allowing tobacco control professio-nals to find and exchange the latest,most accurate information and analy-sis, access specific publications, gui-delines and reports, and engage incollective action.

In 2007, GLOBALink underwentan independent technical review byForum One Communications, USA,and MAHITI, India. With theadvent of a new generation of webtechnologies and services, thesereviews are a critical step in helpingGLOBALink to set priorities for itsnext phase.

GLOBALink is a community net-work that provides multilingualtobacco control news and research,

global tobacco control forums, amembers’ helpdesk, an online peti-tion service, community sharing,mutual help, problem solving, and aninformation exchange platform. Allof these services are outreach systems,where the need for members to visitthe GLOBALink website has been

limited. In line with new web deve-lopments and the rapid expansion oftobacco control in recent years,however, GLOBALink now needs tocreate an up-to-date web portal.

The GLOBALink website was cus-tomized to meet the evolving needsof tobacco control users. After ser-

ving the tobacco control communitywell for more than 14 years, thishomegrown IT system is now sho-wing its age, and the MAHITI reportstrongly suggests a change to a stan-dard content management system(CMS).

This constructive review provides aguideline for GLOBALink’s future.Implementation of its recommenda-tions will be determined by resourceavailability, service continuity, mem-bers’ participation, and staff training.

UICC is grateful to the OpenSociety Institute and the BloombergGlobal Initiative for commissioningthe external technical consultants andto Adin Miller and Dr Judith Wattfor managing the process. We wouldalso like to thank Dr David Hill’soffice for collating a survey of seniorGLOBALink members.

“I love my smoke-free childhood”For the first full-year theme in its

five-year cancer prevention cam-paign, “Today’s children, tomor-row’s world” (see page 10), UICCchose a global initiative to promotesmoke-free environments for chil-dren.

Children exposed to second-handsmoke in homes or cars breathe indozens of cancer-causing chemicals,the campaign – intended to launchon World Cancer Day 2008 – tellsparents.

“Exposure to tobacco smokecauses death, disease and disability,”says Article 8 of the FCTC.Countries that ratify the conventioncommit themselves to protect theircitizens by legislating against expo-

sure to second-hand smoke in work-places and public places. But legisla-tion cannot protect children fromexposure to tobacco smoke in thetwo places where they are most vul-nerable: at home and in cars.

It is difficult for young children toavoid or complainabout second-hand smoke, butthey are more atrisk because theirimmune systemsare not fully deve-loped. The riskincreases withexposure to higherconcentrations oftobacco smoke

and longer periods of exposure. Only100% smoke-free environments pro-tect children from the serious healthproblems that breathing second-handsmoke causes.

Children depend on adults to makesure their air is smoke-free.

Uni

ting

to c

ontr

ol t

obac

co

Luk

Joos

sens


16

Dr

Supa

rna

Seng

upta

, Ind

ia, r

ecip

ient

of

a Ya

mag

iwa-

Yosh

ida

Mem

oria

l int

erna

tiona

l stu

dy g

rant


Knowledge transfer aims tobridge the gaps in cancercontrol between what is

known scientifically and what is donepractically. Equally, it aims to end thegreat disparities in access by differentcommunities and groups to high-quality cancer information, preven-tion, screening and early detection,treatment and care. If existing know-ledge were applied equitably, theglobal cancer burden would be signi-ficantly reduced.

Transforming knowledge into action

! Make the case that investment in solving the cancer problem is an investment inthe health of the population and therefore an investment in a country’s economichealth

! Adopt appropriate evidence-based guidelines for early detection and treatmentprogrammes and tailor priority actions to different socio-economic, cultural andresource settings

World Cancer Declaration 2006

17

Tran

sfor

min

g kn

owle

dge

into

act

ion

In 2007, UICC awarded 155 fellowshipsAmerican Cancer Society international fellowships for beginning investigators (ACSBI) 5

Yamagiwa-Yoshida Memorial international cancer study grants (YY) 13

International Cancer Technology Transfer (ICRETT) fellowships 123

International Cancer Technology Transfer (ICRETT) training workshops 7

Trish Greene international cancer nursing training workshops (CNTW) 1

Asia-Pacific Cancer Society training grants (APCASOT) 6

Total 155

Access to cancer drugs

International cancer fellowships

UICC’s fellowships programmesimpart skills that cut across the cancercontinuum from prevention to end-of-life care to those who are on thefrontlines of cancer research and can-cer care. Thanks to the generosity ofsponsors and the expertise of volun-teer reviewers, nearly 6,000 healthprofessionals have benefited fromUICC fellowships.

Almost one person in three world-wide has no access to full and effectivecancer treatment with the medicinesthey need. Even in highly developedcountries, access to the best cancertherapy is not guaranteed for all.

In November, the UICC board ofdirectors adopted a position papercalling for transparency in pricing andequity in access to cancer drugs.

Many countries cannot afford thehigh price of patent-protected cancer

drugs, the board says. Patent enforce-ment by pharmaceutical companiesin low-income countries can alsoinhibit access.

Cancer drugs account for 10-20%of spending on cancer care. Sales of

ICRE

TT f

ello

w D

r Pe

dro

Ríos

, Per

u

cancer drugs reached $34.6 billion in2006, up 20.5% from 2005. Somegovernments do not provide reimburse-ment for essential cancer drugs, leavingpatients to pay for them themselves.

Drug development is mainly driven bycommercial considerations. The phar-maceutical industry spends $6.5-8 bil-lion each year on cancer research;government and non-profit investmentis much lower. Few if any drugs areavailable to treat rarer cancers.

Targeted therapies are revolutionizingthe way cancer is managed, but theirprice is high and getting higher. As moretargeted therapies are used for long-termmaintenance, the overall cost of cancercare will increase significantly and formany countries may become unafforda-ble.

The paper is intended to stimulate dis-cussion on ways of promoting moreequitable access to optimal cancer careworldwide, and comments are welcome.


18

Public policy and the challenge of chronic non-communicable diseases

A World Bank report published in June 2007 warns that poorcountries are catching up with wealthier nations in cancer, dia-betes, obesity, and heart disease, and that by 2015 these chronicillnesses will be the leading cause of death in developing coun-tries. The report calls for actions to slow down the trend andprepare for heavy demand on health-care budgets.

The social and economic costs of NCDs can be very expen-sive. About three-quarters of the NCD disability burden in low-and middle-income countries falls on those aged 15 to 69, at thepeak of economic productivity.

Public Policy and the Challenge of Chronic Non-communicableDiseases says that these countries need to promote healthy ageingand avoid premature deaths. They also need to adapt their healthsystems to cope with the growing numbers of elderly peoplewho will require long-term care and request expensive treat-ment.

“An exclusive focus on prevention may lead to unrealisticexpectations of a disease-free future and a failure to prepare foremerging challenges,” says Olusoji Adeyi, the World Bank’scoordinator for public health programmes, who led the team thatwrote the report. “We find a compelling case for actions on bothfronts; avoiding much of the chronic disease burden, and prepa-ring to deal with large demands on health budgets and systems.”

“Many studies tend tounderestimate the realcost of non-communi-cable diseases to indivi-dual people and theirfamilies, which cancause a household toslip below the povertyline. When a familymember falls sick witha chronic illness, fami-lies in developing coun-tries often tap into theirmeagre savings, or sellwhat they own to coverthe costs of care andlost wages. Anotherway families cope is to have women andchildren care for their

sick relatives, which can mean that children have to leaveschool during a health crisis to care for a sick older relative,earn extra money, or use money put aside for their educa-tion to help cover medical costs. Although these effects ofpoor health are not unique to NCDs, the longer duration ofchronic disease makes the financial costs heavier than inthe case of acute illnesses.”

Joy Phumaphi Vice-president of the World Bank’s

human development network and formerly minister of health in Botswana

Assessing oncology needs ina Kenyan hospital

Resources for cancer treatment arelimited in Kenya, with only three radia-tion machines for 30 million people –Canada has 140 machines for the samepopulation.

In July-August 2007, Timothy Hanna,a senior resident in radiation oncology inKingston, Ontario, and his Canadiannursing colleague Jeanette Suurdt spenttwo months as ICRETT fellows helpingto work out a plan to treat cancerpatients in AIJ Kijabe hospital.

Kijabe is a 240-bed charity referralhospital open to all Kenyans, focusingon those with limited or no financialmeans. About 500 new cancer cases pre-sent each year, despite a lack of resourcesfor treatment.

The two fellows built relationshipsand understanding through interactiveteaching sessions with nurses, doctors,residents and medical students. Theytaught the basic principles of oncologyto over 100 nurses and provided practi-cal education on cytotoxic precautions.They developed some cancer preventionresources based on WHO and UICCinformation, some of which was laterused in a presentation to the Ugandanparliament. They also treated the firstcase of childhood leukaemia the hospitalhad ever attempted, in partnership with


Dr Elizabeth Korthoff, a paediatriconcologist from the Netherlands.

The plan eventually adopted wasto begin by expanding chemotherapyservices, where capital costs are lower

than in radiotherapy. The first can-cers to be treated are breast cancer,Kaposi’s sarcoma, and surgically trea-table cervical cancer. Kijabe has alsostarted a dedicated palliative care pro-

gramme. Its importance is clear: mostof the patients treated at HospiceUganda and Hospice Kenya are can-cer patients.

19

Tran

sfor

min

g kn

owle

dge

into

act

ion

In 2007, UICC funded sevenworkshops in Cuba, Cyprus, India,Turkey, and Uganda.• Advanced radiotherapy treatment plan-

ning: principles and practice,Advanced Medicare ResearchInstitute Hospitals, India, led by DrBernard Mijnheer, NetherlandsCancer Institute

• Data quality in cancer registry,Instituto Nacional de Oncología yRadiobiología, Cuba, led by DrMaría Isabel Izarzugaza Lizarraga,Department of Health, Basque

Government, Spain • Flow cytometric analysis of tumour

cells, Institute of ExperimentalMedicine, Istanbul University,Turkey, led by Dr Awtar KrishanGanju, University of Miami Schoolof Medicine, USA

• Mechanisms and epidemiology of cancerwith focus on Africa, MakerereUniversity, Uganda, led by Dr BoLambert, Karolinska Institute,Sweden

• Proliferation, apoptosis and signal trans-duction, Jawaharlal Nehru

University, India, led by Dr AwtarKrishan Ganju, University ofMiami School of Medicine, USA

• Setting priorities in radiotherapy-techno-logy and access, Dr Rai MemorialCancer Institute, India, led by DrKrishnaswamy Madhavan,Southend University Hospital, UK

• Stresses of working with cancer patients,Ministry of Health, Cyprus, led byDr Michael Silbermann, MiddleEast Cancer Consortium

ICRETT training workshops

“It was so exciting to help the staff atKijabe work through what it wouldmean to have a cancer programme attheir hospital and develop a concreteplan to phase it in. This fellowship wasan incredible experience for both of us,and we hope it will serve as encourage-ment to other oncologists and health-care workers to contribute to the fightagainst cancer in low- and middle-income countries.”

Timothy Hanna and Jeanette Suurdt

Makerere University, on the outs-kirts of Kampala, Uganda’s capital,was the venue for an ICRETTworkshop in January. The pro-gramme included cancer aetiology,epidemiology, and the mechanismsof carcinogenesis and cancer preven-tion.

A mixed faculty of Ugandan andforeign cancer experts taught a classof 20 students drawn from the uni-versity medical school, Mulago hos-pital, and the Ugandan ministry ofhealth. Three scientific seminarswhere PhD students presented theirwork in cervical cancer aetiology,cervical cancer screening, andconjunctival cancer were especiallyuseful.

“All students could see how inpractice projects in cancer epidemio-logy can be planned and implemen-

ted, and which results one mayexpect, and how one may interpretsuch results,” says Dr NelsonSewankambo, dean of the faculty ofmedicine, who coordinated thecourse.

The course was originally plannedto last six days but, thanks to the inte-rest of the stu-dents, was exten-ded for a furtherfour. This allowedfor several practi-cal exercises indata managementand data analysis.Dr Sewankamboexpects that thestudents will nowbe able to use thedata from theKiadondo cancer

registry, which covers the Kampalaregion, in their own research.

He also hopes that the Ugandanteachers – and perhaps some of thestudents already engaged in cancerresearch – will eventually take overthe task of teaching epidemiology.

Mechanisms and epidemiology of cancer in Africa

ICRE

TT f

ello

w D

r O

lani

sun

Ade

wol

e, N

iger

ia,

durin

g a

bron

chos

copy

ses

sion


20

In low- and middle-income coun-tries the need to reconcile technolo-gical advances with access to morebasic cancer treatment is stark.

Chennai was the venue for anICRETT workshop in November2007 on setting priorities in radiothe-rapy. Two sessions looked at access;three sessions discussed technology incancers of the prostate, head andneck, and cervix; and a sixth sessionfocused on emerging technologies.

An overview was given on the greatleap forward from 2D to 3D radiothe-

rapy and itsm o d e r n i z i n gi m p l i c a t i o n s .Standards andt e c h n o l o g i c a lrequirements inthe three tumoursites were discus-sed, and the statusof such interven-tions as PET scan-ning, helical tomo-therapy and ste-reotactic radiosur-

gery was reviewed. The minimum provision

to deliver effective radiothe-rapy across the entire popu-lation was debated. Ensuringaccess remains the funda-mental step towards enhan-cing quality of cancer care.

The workshop was orga-nized by Dr KrishnaswamyMadhavan together with theAssociation of RadiationOncologists of India(AROI) and embedded in

the annual AROI meeting, hosted bythe Dr Rai Memorial Cancer Centre.Participants were senior radiationoncologists, radiation physicists,heads of cancer centres, and senioroncologists from India’s corporatehealth-care sector.

Two working groups were formedto develop a consensus statement ontechnology and access that will serveto inform policymakers and commis-sioners of radiotherapy in low- andmiddle-income countries. The state-ment and a monograph of the pro-ceedings will be published in 2008.

Setting priorities in radiotherapy

TNM“Seismic shift” in lung cancer staging

Tumour, node, metastasis (TNM)staging has been the basic classifica-tion for all solid tumours for decades.Developed by Dr Pierre Denoix ofFrance, it was adopted by UICC in1953. Use of this system has assistedhealth-care providers in selectingappropriate therapies for patients andhas defined appropriate populationsfor clinical research.

In 1998, the InternationalAssociation for the Study of LungCancer (IASLC) launched a world-wide TNM staging project for lungcancer. A decade of intense studycame to fruition in a flurry of articles

in July and August 2007 in the Journalof Thoracic Oncology.

The IASLC proposals for revisionof the staging system are based onanalyses of 67,725 cases of non-smallcell lung cancer. In an editorial in thejournal in July, Dr Katherine Pistersand Dr Gail Darling congratulate theIASLC on the huge task it has suc-cessfully tackled. But they add, “Thestaging systems for lung cancer and,indeed, for all solid tumours repre-sent a work in progress. We look for-ward to the day when accurate surgi-cal and molecular staging will accura-tely predict prognosis. ”

In an editorialin August, DrGerard Silvestriechoes this cau-tion: “Even withthe size andscope of thisundertaking, thestaging systemremains a relati-vely crude pre-dictor of survival.

Recent forays into tumour proteinexpression and cancer genomics haveprovided a glimpse into how we mayimprove our ability to predict out-come among those within a givenstage grouping. One can envision atime in the not too distant futurewhen stage will be based on both theTNM classification and moleculardiagnostics. Until then, let us admirethe work of those who built the sta-ging system over the past 30 yearsand embrace the proposal for a newclassification for lung cancer.”

Meeting in May, UICC’s TNMcore committee recommended thatthe IASLC proposal be accepted forinclusion in the seventh edition ofthe TNM Classification of MalignantTumours, scheduled for publication in2009.

“The IASLC's work is a tremen-dous contribution,” says Dr LeslieSobin, chair of the TNM project. “Iconsider it a model for internationalcooperative groups preparing futureproposals for TNM revisions.”

ICRETT fellow Dr Antonella Sgura, Italy

Dr Frances Calman, Dr G Selvaluxmy, Dr SK Srivatsava and Dr SBhoopal from the workshop faculty

Dr Leslie Sobin (left) chairs an animated discussion in the TNM committee


Health organizations face a gro-wing need to standardize health poli-cies and practices, in order to pro-mote optimal, evidence-based, andequitable patient care and managefinite resources better. But the deve-lopment and updating of high-qua-lity clinical practice guidelines itselfrequires substantial resources.

ADAPTE is an international colla-boration of researchers, guidelinedevelopers, and guideline implemen-ters who aim to promote the deve-lopment and use of clinical practiceguidelines by adapting existing gui-delines, thus reducing cost and dupli-cation of effort. The group’s mainendeavour is to develop and validate

a generic adaptation process that willfoster valid and high-quality adaptedguidelines, as well as their users’sense of ownership.

ADAPTE is a collaboration bet-ween the Quebec Cancer ControlDepartment and the standards,options and recommendations (SOR)project of the French NationalFederation of ComprehensiveCancer Centres.

21

Tran

sfor

min

g kn

owle

dge

into

act

ion

Enhancing efficiency in guideline development and utilization

“We believe that ADAPTEoffers added value to UICCand its members in theiraim of translating scientificevidence into improvedcancer strategies and poli-cies and will organize atraining workshop forADAPTE at the WorldCancer Congress in 2008.”

Dr Thierry Philip Director, Centre d'oncologie

Léon Bérard, and UICC board of directors

International Journal of Cancer

The International Journal of Cancer,UICC's official research organ, is edi-ted by Dr Harald zur Hausen andpublished by John Wiley & Sons.

A leading cancer journal, with 30issues per year, it, offers rapid, robustpeer-review and publication on allaspects of experimental and clinicalcancer research. It is available in printand online: www.interscience.wiley.com

In 2007, the editorial office inHeidelberg, Germany, handledalmost 3,000 manuscripts.Impressively, the average time fromsubmission to first decision is lessthan 25 days. The 2007 impact factoris 4.555 (© ISI Journal CitationReports 2008). Accepted articles aredisseminated globally and made avai-lable in more than 5,000 institutionsworldwide.

In 2009, the journal's online func-tionality will be significantly aug-mented as John Wiley & Sonsembark on a major upgrade to theirweb platform.

UICC strategic leader honoured in AmmanIn September, Dr Joe

Harford, UICC strate-gic leader for know-ledge transfer anddirector of the USNational CancerInstitute’s office ofinternational affairs,received an awardfrom the Arab MedicalAssociation AgainstCancer in recognitionof a decade of work inthe Middle East.

Faisal Al Fayez, the former prime minister of Jordan, presentedDr Harford èwith the award at a gala dinner during the MiddleEast and North Africa cancer research conference in Amman.

The citation on the award reads “In recognition for his signifi-cant contribution to enhance the status of cancer care and cancerresearch in the region and for his unwavering efforts to supportneeded infrastructure and create opportunities in cancer educa-tion, training and capacity building to help cancer patients andtheir families throughout the Arab world.”

The TNM prognostic factors pro-ject goes from strength to strength. Arecord number of national commit-tees promote and disseminate cancerstaging worldwide, while over 100experts assist the project in criticalappraisal of literature and knowledgesynthesis.

An Arabic translation of the sixth

edition of the TNM Classification ofMalignant Tumours appeared in 2007and will be distributed free of chargein Arab countries. The text wastranslated by Dr Dalia Aboul-Azmand revised by Dr Mohamed Lotayef,under the supervision of Dr SherifOmar, a member of the formerUICC council.


22

The

Can

cer

Cou

ncil

Que

ensla

nd


23

Building capacity and supporting patients

In UICC’s institutional develop-ment 2007 was a pivotal year.The decades-long system of

national representation was abando-ned and replaced by individual orga-

nizational membership. In parallel,members from low and middle-income countries were offered anopportunity to reduce their dues. Bythe end of the year, the new system

showed positive results. Severalorganizations either joined or main-tained their membership despitetheir financial problems.

! Consistently deliver a set of compelling messages that can be tailored todifferent country settings and to traditional and non traditional partners

! Increase the number of countries that make pain relief and palliative carean essential service in all cancer treatment and home-based care

! Increase the number of opportunities for people living with cancer andthose touched by cancer to participate fully in community, regional, andcountry cancer control efforts

World Cancer Declaration 2006

Build

ing

capa

city

and

sup

port

ing

patie

nts

Ankara Hope Lodge opens its doorsPeople living with cancer come

from all over Turkey to HacettepeUniversity Oncology Hospital inAnkara. Many face a major problem– where to find safe, clean and affor-dable lodging while they are beingdiagnosed and treated. On 23January, Hacettepe Hope Lodge,next door to the hospital, welcomedits first guests.

The lodge, with 10 rooms forpatients and their families, was builtby the Hacettepe Oncology InstituteFoundation, in partnership with the

Turkish Association for CancerResearch and Control and UICC.Construction began in March 2005,thanks to a generous donation fromthe BNP Paribas Foundation,Switzerland, negotiated throughUICC.

“This Hope Lodge is the first inTurkey,” says Dr Tezer Kutluk, pre-sident of the Turkish Association forCancer Research and Control. “Wehope that it will serve as a model forsimilar projects elsewhere in ourcountry, and in other countries too.”

Breast cancer survivors unite in Stockholm

Queen Silvia of Sweden spoke atthe opening ceremony of “Uniting inRecovery”, the 14th UICC Reachto Recovery International breast can-cer support conference, which met inStockholm, Sweden, at the end ofMay.

The meeting focused on the latestdevelopments in breast cancer care,

including peer supportive care, patientempowerment, prevention, earlydetection and community mobiliza-tion. Delegates representing over 50countries networked, shared informa-tion, and discussed ways to face chal-lenges and overcome barriers.

The conference was hosted by theSwedish Breast Cancer Association

Dr Tezer Kutluk with guests at the Hope Lodge

Que

en S

ilvia

of

Swed

en


24

and the Swedish Cancer Society.With support from Susan G Komenfor the Cure and Bristol-MyersSquibb, UICC grants enabled manyparticipants from resource-constrai-ned countries to attend.

Ann Steyn, who has played a keyrole in training Reach to Recoveryvolunteers throughout Africa, is thenew president of Reach to RecoveryInternational.

AwardsMaria Cunha Matos received the

Terese Lasser award, which isconferred on a Reach to RecoveryInternational volunteer who hasintroduced, initiated, or contributedto the development of a newReach to Recovery programme inan exceptional way.

Maria, a breast cancer survivorsince 1994, has been a Reach toRecovery volunteer with Vencer eVivir in Lisbon since 1996 and hasbeen a key figure in the twinningprogramme between Portugal andLatin America.

Olwyn Ryan received the HealthProfessional Volunteer award, reco-gnizing her exceptional contribu-tion to breast cancer support.

UICC launched the Global CancerControl Community in September2007 as an interactive website forcancer control professionals andvolunteers. New features areconstantly being added.

Members of the community cannetwork with peers around the

world, share and access information,discuss and debate cancer control,and contribute to activities and pro-grammes of the World CancerCongress. By the end of the year,well over 1,000 people had joinedthe community.

Global Cancer Control Community

Many voices, one mes-sage.

Basic rules of communi-cation counsel us to joinforces and link our activitiesto topical themes. Everyspring, the Cancer Societyof Finland, the FinnishMeteorological Institute,and the Radiation andNuclear Safety Authorityhold a joint press confe-rence on being sensible inthe sun.

“We find working toge-ther very natural and easy,and we have been able tofind newsworthy themes,”says Dr Matti Rautalahti,chief medical officer of the cancer society, who is responsible forhealth promotion.

This year, for the first time, the incidence of cutaneous mela-noma among women was lower than the year before. “It is tooearly to see the drop as a trend, but certainly it is a promisingsignal,” Rautalahti says.

Strategic health communication in Finland

Ann

Ste

yn


Build

ing

capa

city

and

sup

port

ing

patie

nts

25

The UICC cancer capacity-buil-ding fund helps member organiza-tions in low- and middle-incomecountries to reach to local communi-ties with evidence-based activities.The fund was launched in October2007, and the project theme for 2008was promotion of tobacco preventionactivities related to the "I like mysmoke-free childhood" campaign.

Strategic project grants ofUS$10,000-15,000 are intended toimprove the capacity of members todevelop and implement cancercontrol programmes. Small grants ofup to US$3,000 are intended to buildthe cancer control capacity of staffand volunteers in member organiza-tions.

The fund was established with

contributions from countries imple-menting Relay For Life, an eventlicensed and supported through trai-ning and technical assistance by theAmerican Cancer Society, a UICCmember organization.

The results of the first call for pro-jects are now available on the UICCwebsite; a new call for projects willbe launched in September 2008.

European communicators meet in GstaadUICC brought communicators from seven European mem-ber organizations to a round table in Gstaad, Switzerland,during the Menuhin Festival in September.

Dr Emmanuelle Bara (National Cancer Institute, France), DrVolker Beck (German Cancer Society), Isabelle Carrel Rothe(Swiss Cancer League), Peter Flynn (Cancer Research UK),Cora Honing (Dutch Cancer Society), Satu Lipponen(Cancer Society of Finland) and Maria Prigorowsky(Swedish Cancer Society) presented their organizations andbrainstormed ways of working together more closely. Theyalso helped to firm up ideas for World Cancer Day 2008.

“I had a very fruitful time,” says Maria Prigorowsky. “It feltlike a start for our future collaboration, a process that ismuch easier now that we have met.”

Cancer capacity-building fund

Better togetherCancer patient groups provide

much-needed services to cancerpatients and their families, but theiractions are rarely recorded or asses-sed. To support the development ofeffective and sustainable cancerpatient groups, particularly inresource-constrained countries,UICC conducted a pilot project withselected groups in Romania andCroatia.

Based on a series of interviews andobservations, the researchers evalua-ted the capabilities of each group andmade specific recommendations toincrease their capacity. Better Together,the report summing up the findings of

the pilot project, will be published in2008 to help build the capacity of

patient groups in south-easternEurope and elsewhere.

The Cancer Society also workswith the Finnish Heart Associationand the Finnish HorticulturalProducts Society to promote a heal-thy diet, with a better intake of fruitsand vegetables. The programme isespecially active in schools duringSeptember and October.

A third area of cooperation is smo-

king prevention. The Cancer Societyworked actively with other non-governmental organizations to makeall restaurants, pubs and bars inFinland smoke-free.

Smoking among adults in Finlandhas been dropping for some time, buttobacco use by young people hasshown a slightly different trend. This

is why the Cancer Society has beencoordinating tobacco use cessationactivities, with tailored messagesaimed at young people.

The result? Smoking prevalenceamong young people is now alsoshowing a downward trend.


26

Spanish association targets men

Pink October is breast cancer aware-ness month. All over the world, nationalcancer societies, breast health founda-tions and breast cancer support groupspromote awareness of the importanceof screening and early detection.

In 2007, the Asociación EspañolaContra el Cáncer shifted its target fromwomen to the men in their lives, encou-raging sons, grandsons, brothers, fian-cés, husbands and fathers to urgewomen in the age groups most at riskto have regular mammograms.

Burundi debates the challenge of cancer

Burundi, a resource-poor country in Africa’s Great Lakesregion, recently emerged from 13 years of civil war but stillfaces many challenges. At the end of September, the Allianceburundaise contre le cancer, a new UICC member, held aconference on what can be done about cancer.

“Unfortunately, due to the immense problems of diagnosisand the lack of qualified personnel and resources, we lack relia-ble figures for cancer incidence and mortality in our country,”said Dr Rosa Paula Manariyo, president of the alliance. “Butcancer is certainly among us. Everyone here bears the mark ofmourning caused by cancer.”

Estimates from the International Agency for Research onCancer rank Kaposi’s sarcoma as the leading cancer in Burundi– about one in 15 adults has HIV/AIDS – and cervical canceras the leading cancer in women. Surgery is almost the onlymode of treatment for cancer in Burundi.

It is unacceptable to leave cancer patients and their familiestorn between seeking care abroad or resigning themselves todeath, said Dr Pie Ntavyohanyuma, the president of the natio-nal assembly. He looked forward to the creation of a nationalcancer treatment centre.

A report published for WorldHospice and Palliative Care Day inOctober investigates the widespreadlack of access to pain relief in manyparts of the world, highlighting thefact that cost is not usually the mainbarrier.

The report showcases a new surveyof 69 hospice and palliative care ser-vices in Asia, Africa and LatinAmerica, as well as synthesizing glo-bal data about access to pain relief.

It finds that around 80% of theworld’s cancer sufferers have noaccess to analgesics and that an esti-mated 7% of all people in the worldsuffer cancer pain that could be relie-ved but is not.

Most of the people denied painrelief are in developing countries,where the incidence of pain is also

often higher. The main barriers toaccess are not cost, but rather lack ofeducation and training, bureaucracy,excessively strict legislation, mispla-ced fear of addiction, abuse, toleranceor side effects, and poorly developedhealth systems and supply chains.

The report outlines essential stepsthat need to be taken including

improved education and accountabi-lity, reviewing laws and policies andstrengthening health facilities.Palliative care and access to analgesicsshould be an integral part of all natio-nal policies relating to cancer,HIV/AIDS and other chronicdiseases, it says.

Report exposes lack of access to analgesics

Dr Rosa Paula Manariyo welcomes Dr Pie Ntavyohanyuma


More than a quarter of a milliondollars was raised for childhood can-cer research in November 2007 at thefirst annual “Naomi’s Hope for aCure” in the National Building

Museum, Washington DC. Children with cancer

today are still treated withcytotoxic drugs develo-ped 20 to 30 years ago.The money collected atthe gala event by theCandlelighters ChildhoodCancer Foundation, aUICC member organiza-tion, will go to researchinto new “smart drugs”to give them hope for the

future and a complete cure. Members of congress, sports cele-

brities, cancer leaders, corporateCEOs, community supporters, andchildhood cancer families attended

the gala, which was organized byNaomi Bartley, the daughter of RuthHoffman, Candlelighters’ executivedirector. November was whenNaomi celebrated the 20th anniver-sary of the allogeneic bone marrowtransplant that saved her life.

In 1987, when she was seven,Naomi was treated for acute myelo-genous leukaemia (AML). Livingwith chronic health problems resul-ting from the aggressive treatment shereceived as a little girl, Naomi joinsher mother in raising research dollarsand an awareness of the need for lesstoxic targeted therapies to treat chil-dhood cancer.

27

Naomi hopes for a cure

“My child matters” to enter third yearUICC launched the “My child

matter” initiative in 2006 to supportchildren with cancer and their fami-lies in low- and middle-incomecountries. “My child matters” is thelargest and most comprehensive chil-dhood cancer programme inresource-constrained settings.

In June, the scientific abstract“Evaluation of paediatric oncologycare in 10 countries taking part in theMy child matters programme” was

presented at the annual meeting ofthe American Society of ClinicalOncology. The ASCO cancer com-munications committee also chose tohighlight it in the official press pro-gramme.

“My child matters” is a UICC/sanofi-aventis partnership.

In December 2007, 18 projectswere selected for second- or third-year funding (see list below).

Pilot projects (2006): support for year three

BangladeshASHIC palliative care unit (Salma Choudhury)Childhood cancer campaign (MA Mannan)

EgyptWe are the children, we are the world (Ayman Omar)

HondurasSatellite clinics (Ligia Fu)

MoroccoEarly diagnosis (Fouzia Msefer Alaoui)Pain management (Mohamed Harif)

PhilippinesCanServe project (Julius Lecciones)

SenegalContinuous care unit (Claude Moreira)

TanzaniaBurkitt's lymphoma (Twalib Ngoma)

VenezuelaPsychosocial and nutritional support (Claudia Sánchez Machuca)

VietnamCompetence in prevention, care, and support (Nguyen Ba Duc)

Second-year projects (2007): support for year two

Bolivia Free leukaemia diagnosis (Ricardo Amaru Lucana)Early diagnosis and follow-up (Yolanda Ernst)

Indonesia Early detection, referral and treatment (Melissa Luwia)

Kenya Burkitt's lymphoma (Nicholas Anthony Othieno Abinya)

Mali Oncopedia Mali (Boubacar Togo)

Peru eLearning (Gustavo Sarria Bardales)Albergue ALDIMI (Nelly Isabel Therese Huamaní)

Romania Improving diagnostic services (Doina Mihaila)

“There is hope”: Canadian Cancer Society, Relay For Life, Montreal

Build

ing

capa

city

and

sup

port

ing

patie

nts

Naomi Bartley and Ruth Hoffman

Africa African Oncology Institute, Libya Agir Ensemble, CongoAlliance burundaise contre le cancer, Burundi Association Ennour d'aide aux malades cancéreux, Algeria Association Lalla Salma de lutte contre le cancer, Morocco Association tunisienne de lutte contre le cancer, Tunisia Cancer Association of Namibia Cancer Association of South Africa Cancer Association of Zimbabwe Care Organization Public Enlightenment,Nigeria Fakkous Centre for Cancer and AlliedDiseases, Egypt Institut Salah Azaiz, Tunisia Kasr El Ainy Centre of Radiation Oncologyand Nuclear Medicine (NEMROCK), Cairo,Egypt Kenya Cancer Association Kenya Medical Research Institute National Cancer Institute, Cairo, EgyptMathiwos Wondu – YeEthiopia CancerSociety, Ethiopia Nigerian Cancer Society, NigeriaOcean Road Cancer Institute, Tanzania Society of Oncology and Cancer Research ofNigeria Tous unis contre le cancer, Niger Uganda Women's Cancer Support OrganizationYe Ethiopia Cancer Association, Ethiopia

Asia and the Pacific Aichi Cancer Centre, Japan Bangalore Institute of Oncology, India Bangladesh Cancer Society BP Koirala Memorial Cancer Hospital, Nepal Breast Cancer Welfare Association, Malaysia Cancer Aid and Research Foundation, India Cancer Centre Welfare Home and ResearchInstitute, India The Cancer Council ACT, Australia The Cancer Council Australia The Cancer Council New South Wales, AustraliaThe Cancer Council Northern Territory,Australia The Cancer Council Queensland, Australia The Cancer Council South Australia The Cancer Council Tasmania, Australia The Cancer Council Victoria, Australia The Cancer Council Western Australia Cancer Institute (WIA), India Cancer Institute of JFCR, Japan Cancer Patients Aid Association, India Cancer Society Nepal Cancer Society of New Zealand Chiba Cancer Centre, Japan Chinese Anti-Cancer Association (CACA) Chinese Medical Association Chinese Oncology Society, Taiwan, China Dharamshila Cancer Hospital and ResearchCentre, India Dr B Borooah Cancer Institute, India Ergene Public Foundation, KyrgyztanFiji Cancer Society Foundation for Promotion of CancerResearch, JapanFukuoka Cancer Society, Japan Gujarat Cancer and Research Institute, India Hokkaido Cancer Society, Japan Hong Kong Anti-Cancer Society, China Ho Chi Minh City Oncological Hospital,Vietnam Hope Society for Cancer Care, Taiwan, China Indian Cancer Society Indonesian Cancer Foundation Institute of Cytology and PreventiveOncology, India

Institute Rotary Cancer Hospital, India Japan Cancer Society Japan Lung Cancer Society Japan Society of Clinical Oncology Japanese Breast Cancer Society Japanese Cancer Association Japanese Foundation for MultidisciplinaryTreatment of Cancer Jikei University School of Medicine, Japan John Tung Foundation, Taiwan, China Kanagawa Cancer Centre, Japan Kidwai Memorial Institute of Oncology, India Korea Association of Health Promotion Korea Institute of Radiological and MedicalSciences Korean Cancer Association Korean Cancer Society Meherbai Tata Memorial Hospital, India Ministry of Health, Indonesia Ministry of Health, Pakistan Miyagi Cancer Society, Japan National Breast and Ovarian Cancer Centre,Australia National Cancer Centre, Japan National Cancer Centre, Korea National Cancer Centre, Singapore National Cancer Council (MAKNA), Malaysia National Cancer Institute, Thailand National Cancer Institute, Vietnam National Cancer Society of Malaysia National Oncological Centre, Mongolia Nepal Cancer Relief Society (NCRS) Netaji Subhash Chandra Bose CancerResearch Institute, India Niigata Cancer Centre, Japan Osaka Cancer Foundation, Japan Osaka Medical Centre for Cancer andCardiovascular Diseases, Japan Pakistan Atomic Energy Commission Peter MacCallum Cancer Institute, Australia Philippine Cancer Society Princess Takamatsu Cancer Research Fund,Japan Prostate Cancer Foundation of Australia Rajiv Gandhi Cancer Institute and ResearchCentre, India Ruby Hall Clinic Kamalnayan Bajaf CancerCentre, India Saitama Cancer Centre, Japan Sapporo Cancer Seminar Foundation, Japan Sasaki Institute and Foundation , Japan Science Council of Japan Shaukat Khanum Memorial CancerHospital and Research Centre, Pakistan Shizuoka Cancer Centre, Japan Singapore Cancer Society Taiwan Cancer Foundation, Taiwan, China Taiwan Cancer Society, Taiwan, China Tata Memorial Centre, India Thai Cancer Society Tianjin Medical University Cancer Instituteand Hospital, China Tochigi Cancer Centre, Japan Tokyo Metropolitan Komagome Hospital, Japan Walter and Eliza Hall Institute of MedicalResearch, Australia

Europe Academisch Medisch Centrum, Netherlands Action Cancer, UK Asociación Española Contra el Cáncer, Spain Association of Patients with OncologicalDiseases and Friends, Bulgaria Association PAVEL, RomaniaAssociation of Slovenian Cancer Societies Associazione Italiana di Oncologia Medica, Italy Associazione Italiana Malati di Cancro Parentie Amici, Italy Associazione Italiana per la Ricerca sulCancro, Italy

August Kirchenstein Institute of Microbiologyand Virology, Latvia Bulgarian National Association of Oncology Cancer Research UK Cancer Society in Stockholm, Sweden Cancer Society of Finland Centre d'oncologie Léon Bérard, France Centre Georges-François Leclerc, France Centre régional François Baclesse, France Centre régional Jean Perrin, France Centro di Prevenzione Oncologica, Italy Centro di Riferimento Oncologico, Italy Centro per lo Studio E la PrevenzioneOncologica, Italy Cochrane Cancer Network, UK Croatian League against Cancer Danish Cancer Society Deutsche Krebsgesellschaft, Germany Deutsche Krebshilfe, Germany Deutsches Krebsforschungszentrum, Germany Dutch Association of Comprehensive CancerCentres Dutch Cancer Society Een Häerz fir Kriibskrank Kanner, Luxembourg Epidaure CRLC Val d'Aurelle-Paul Lamarque,France Estonian Cancer SocietyEuropean CanCer Organization (ECCO) European Cervical Cancer Association European Institute of Oncology European Organization for Research andTreatment of Cancer European School of Oncology European Society for Medical Oncology European Society of Therapeutic Radiologyand Oncology Federació Catalana d'Entitats contra el càncer,Spain Fédération nationale des centres de luttecontre le cancer (FNCLCC), France Fondation contre le Cancer / Stichting tegenKanker, Belgium Fondazione De Benedetti - Cherasco 1547,Italy Fondazione Edo ed Elvo Tempia Valenta, Italy Fondazione IRCCS Istituto Nazionale deiTumori, Italy Hellenic Cancer Society, Greece Hellenic Society of Oncology, Greece Hungarian League Against Cancer

Algeria

Mali

Senegal

Morocco

Namibia

Nigeria

Cong

Niger

Libyan

South

Tunisia

Argentina

Bolivia

Brazil

Colombia

Venezuela

CubaDominican Republic

Ecuador

El Salvador

GuatemalaHonduras

Mexico

Nicaragua

Peru

Trinidad and Tobago

Uruguay

Belgium

Croatia

Czech Republic

Denmark

Finland

France

Germany

Greec

Iceland

Ireland

Italy

Luxembourg

Netherlands

Norway

Poland

Portugal

Slovenia

Spain

Sweden

Switzerland

United Kingdom

USA

Canada

Panama

Chile

Member or


28


Icelandic Cancer Society Institut Català d'Oncologia, Spain Institut Claudius Regaud, France Institut Gustave Roussy, France Institut national du cancer, France Institut Paoli Calmettes, France Institute of Cancer Research, UK Institute of Oncology, Bucharest, Romania Institute of Oncology, Ljubljana, Slovenia Instituto Português de Oncologia de FranciscoGentil, Portugal International Hereditary Cancer Centre,PolandIrish Cancer Society ISREC Fondation|Stiftung|Foundation,Switzerland Istituto di Ricerche Farmacologiche "MarioNegri", Italy Istituto Nazionale per la Ricerca sul Cancro,Italy Istituto Nazionale per lo Studio e la Cura deiTumori. Fondazione "G Pascale", Italy Istituto Oncologico Romagnolo, Italy Istituto Superiore di Oncologia, Italy Kidney Cancer Research Bureau, Russia Krebsliga Schweiz / Ligue suisse contre lecancer / Lega Svizzera Contro il Cancro,Switzerland League against Cancer, Prague, CzechRepublic Lega Italiana per la Lotta contro i Tumori, ItalyLiga Portuguesa Contra o Cancro, Portugal Ligue nationale contre le cancer, France Lithuanian Oncological Society Lymphoma Coalition, UK Macmillan Cancer Relief, UK Marie Keating Foundation, IrelandMinistère de la Santé, Luxembourg National Cancer Centre of Georgia NN Blokhin Cancer Research Centre, Russia NN Petrov Research Institute of Oncology,Russia Norwegian Cancer Society Oncologic Centre Antwerp, Belgium Paterson Institute for Cancer Research, UK Polish Oncological Society, Poland Regina Elena Cancer Institute, Italy Serbian Society for the Fight against Cancer Slovak League against Cancer Swedish Cancer Society

Ulster Cancer Foundation, UK Università degli Studi dell' Insubria, Italy Westdeutsches Tumorzentrum, Germany World Cancer Research Fund, UK

Latin America and Caribbean Ary Frauzino Foundation for Cancer Researchand Control, Brazil Asociación Hondureña de Luchacontra elCáncer, Honduras Asociación Mexicana de Lucha Contra elCáncer, Mexico Asociación Nacional Contra el Cáncer,Panama Asociación Salvadoreña para la Prevencióndel Cáncer, El Salvador Associação Brasileira Assistencia aosCanceros, Brazil Comisión Honoraria de Lucha contra elCáncer, Uruguay Fundação Oncocentro de São Paulo, Brazil Fundación Boliviana Contra el Cáncer, BoliviaFundación Chilena para el Desarrollo de laOncología, Chile Fundación Hondureña para el Niño conCáncer, Honduras Grupo Brasileiro de Estudos do Câncer, Brazil Hospital de Clínicas "Dr Manuel Quintela",Uruguay Instituto Brasileiro de Contrôle do Câncer,Brazil Instituto de Enfermedades Neoplásicas, Peru Instituto Nacional do Câncer, Brazil Instituto Nacional de Cancerología, Colombia Instituto Nacional de Cancerología, Mexico Instituto Nacional de Oncología yRadiobiología, Cuba Instituto Oncologico Henry Moore, Argentina Liga Argentina de Lucha Contra el Cáncer,Argentina Liga Bahiana Contra o Câncer, Brazil Liga Colombiana Contra el Cáncer, Colombia Liga Contra el Cáncer, Honduras Liga Dominicana Contra el Cáncer, DominicanRepublic Liga Nacional Contra El Cáncer de El Salvador Liga Nacional Contra el Cáncer Guatemala/Piensa Liga Nacional Contra la Leucemia y el Canceren el Niño, Nicaragua Liga Peruana de Lucha Contra el Cáncer, Peru Oncosalud, Peru Patronato Cibaeño Contra el Cáncer,Dominican Republic Sociedad Anticancerosa de Venezuela Sociedad de Lucha contra el Cáncer, Ecuador Sociedad Latinoamericana y del Caribe deOncología Médica Sociedad Mexicana de Oncología, Mexico Sociedad Peruana de Cancerología, Peru Sociedad Peruana de Oncología Médica, Peru Sociedade Brasileira de Cancerologia, Brazil Trinidad and Tobago Cancer Society University of São Paulo, Brazil

Middle East Bahrain Cancer Society, Bahrain Cancer Institute, Imam Khomeini MedicalCentre, Iran Cyprus Anti-Cancer Society Cyprus Association of Cancer Patients andFriends Haematology-Oncology and Stem CellResearch Centre, Iran Iraqi Merciful Organization for Medical andScientific Research and Suppliers of HumanReliefIsrael Cancer AssociationKing Faisal Specialist Hospital and ResearchCentre Jeddah, Saudia Arabia

King Hussein Cancer Centre, JordanKing Hussein Institute for Biotechnology andCancer, JordanKuwait Society for Smoking and CancerPrevention Lebanese Cancer Society MAHAK Society To Support ChildrenSuffering From Cancer, Iran Ministry of Health, Saudi Arabia Ministry of Health, Oman National Cancer Control Foundation, Yemen Patient's Friends Society-Jerusalem (aPalestinian NGO) Qatar National Cancer Society Research Centre of Gastroenterology andLiver Transplantation, Iran Saudi Cancer Society, Saudi Arabia Syrian Cancer Society Turkish Association for Cancer Research andControl

North America Alberta Cancer Board, Canada American Association for Cancer Research, USAAmerican Cancer Society, USA American College of Surgeons, USA American Society for Therapeutic Radiologyand Oncology, USA American Society of Clinical Oncology, USA Arthur G James Cancer Hospital ResearchInstitute, USA BC Cancer Agency, Canada Campaign for Tobacco-Free Kids, USA The Campaign to Control Cancer, Canada Canadian Association of Radiation Oncology Canadian Breast Cancer Foundation -Prairies/NWT Chapter Canadian Cancer Society Canadian Partnership Against Cancer Cancer Care Nova Scotia, CanadaCancer Care Ontario, Canada Candlelighters Childhood Cancer Foundation,USA C-Change (National Dialogue on Cancer), USACentre for Chronic Disease and Prevention,Canada Centre hospitalier de l?Université deMontréal, Canada Centres for Disease Control and Prevention, USACIHR Institute of Cancer Research, Canada College of American Pathologists, USA Colorectal Cancer Association of CanadaFondation québécoise du cancer, Canada Fred Hutchinson Cancer Research Centre, USAH Lee Moffitt Cancer Centre, USA Lance Armstrong Foundation, USA Massey Cancer Centre, USA MD Anderson Cancer Centre, USA National Cancer Institute, USA National Cancer Institute of Canada National Foundation for Cancer Research,USA Oncology Nursing Society, USA Princess Margaret Hospital, Canada Roswell Park Cancer Institute, USA St Jude Children's Research Hospital, USA Susan G Komen for the Cure, USA University of Colorado Cancer Centre, USA Women in Government, USA

International International Brain Tumour Alliance International Confederation of ChildhoodCancer Parent Organizations International Extranodal Lymphoma StudyGroup International Psycho-Oncology Society Ludwig Institute for Cancer Research

Burundi

Uganda

Egypt

Ethiopia

Kenyago

Africa

Zimbabwe

Australia

Bangladesh

China

Fiji

India

Indonesia

JapanKorea

Malaysia

Mongolia

Nepal

New Zealand

Philippines

Singapore

Chinese Taipei

ThailandVietnam

Bulgaria

Estonia

Georgia

ce

Hungary

Israel

Latvia

Lithuania

Romania

Russia

Serbia and Montenegro

Slovakia

Bahrain

Cyprus Iran

Jordan

KuwaitLebanon

Oman

PakistanQatar

Saudi Arabia

SyriaTurkey

Yemen

Tanzania

Kyrgyzstan

Ukraina

Mem

ber

orga

niza

tions

As of August 2008

rganizations

29


30

David HillPresident-electAn Australian, Dr David Hill

was educated in Tasmaniaand Victoria, where he

completed his PhD in psychologyat the University of Melbourne. Heis married, with four adult sons, andhis wife Ann is a medical historian.

Dr Hill appreciated early in hiscareer at the Cancer CouncilVictoria (then the Anti-CancerCouncil of Victoria) that applyinginsights and methods of behaviouralscience would enhance the effec-tiveness of public communicationprogrammes to change cancer-relat-ed behaviours such as smoking,prompt reporting of cancer warningsigns and participation in screening.

In 1986, he was appointed as found-ing director of the Centre forBehavioural Research in Cancer atthe Anti-Cancer Council of Victoria.This was a unique concept at thetime for it located a group of full-time behavioural researchers inside acancer control organization. Theintention was to co-locate researchersand health promotion staff to maxi-mize the adoption of research intopractice as well as to ensure researchproblems addressed were relevant tothe needs of prevention programmes.The model was considered successfuland taken up elsewhere, mostly byUICC member organizations inother states of Australia, NorthAmerica, and Europe. More informa-tion on the centre can be found atwww.cancervic.org.au

Dr Hill’s first association with UICCwas in 1976, when he was asked tolead the UICC project on doctorinvolvement in public educationabout cancer. This project ran until1990 and resulted in a monographand a number of regional trainingactivities, including workshops inMilan, Manchester, Athens,Venezuela, and Israel. Then, as now,medical doctors and in particularfamily physicians were seen as vitalchannels of effective communicationof prevention and screening mes-sages. From 1990 to 1994, he alsoled the UICC project on behaviour-al science applications in cancer pre-

vention, which conducted trainingworkshops in Amsterdam andHalifax (Canada).

He was a member of the UICC’sCampaign Organization PublicEducation and Support (COPES)programme between 1976 and1996. Under the aegis of COPES,Dr Hill ran the first WorldConference for CancerOrganizations in Melbourne in1996. The World Conferencesubsequently met in Atlanta,Georgia (USA), Brighton(England), and Dublin (Ireland)before it was combined with thelong-standing International CancerCongress and became the WorldCancer Congress in WashingtonDC in 2006.

Dr Hill is a professor at threeAustralian universities – theUniversity of Melbourne,Monash University, and DeakinUniversity. He has publishedover 200 scientific papers in areassuch as smoking, screeningbehaviour, sun protection andpatient support.

In 2001, he received a nationalhonour and became a Member ofthe Order of Australia (AM) for“services to the promotion ofcommunity health, particularly inthe development of cancer aware-ness and prevention programmes”.


Dav

id H

ill !

Com

mitt

ees

and

task

forc

es

Committees and taskforces

31

Board of directorsPolicy committeeDavid Hill (chair), AustraliaMary Gospodarowicz, CanadaHarri Vertio, FinlandArun Kurkure, IndiaFred Mickelson, USA

Nominating committeeJohn Seffrin (chair), USAElisabeth Hjorth, DenmarkEliezer Robinson, IsraelTomoyuki Kitagawa, JapanIgnacio Musé Sevrini, UruguayFranco Cavalli (observer),SwitzerlandLouis Denis, BelgiumDavid Hill (observer), Australia

Finance committeeMary Gospodarowicz (chair),CanadaXi-shan Hao, ChinaHarri Vertio, FinlandAlex Markham, UKPearl Moore, USAFranco Cavalli, Switzerland

Membership committeeEduardo Cazap (chair), ArgentinaKetayun Dinshaw, IndiaBruno Meili, SwitzerlandTezer Kutkuk, TurkeyH Fred Mickelson, USA

Cancer drugs ad hoc taskforceEduardo Cazap (chair), ArgentinaThierry Philip, FranceArun Kurkure, IndiaKathy Redmond, ItalyFranco Cavalli, SwitzerlandThomas Cerny, Switzerland

Ad hoc task force on regionalstrategyFranco Cavalli (chair), SwitzerlandEduardo Cazap, ArgentinaXishan Hao, ChinaJoe Harford, USADavid Hill, AustraliaKazuo Tajima, JapanIsabel Mortara

Solidarity fund ad hoc committeeFranco Cavalli (chair), SwitzerlandDavid Hill, AustraliaBarbara Whylie, CanadaAnne-Lise Ryel, NorwayBruno Meili, SwitzerlandIsabel Mortara, UICC

Strategic coordinating committeeFranco Cavalli (chair), SwitzerlandJoe Harford, USAHélène Sancho-Garnier, FranceLuk Joossens, BelgiumKazuo Tajima, JapanJeff Dunn, AustraliaDavid Hill, Australia

Project taskforces

Global Cancer ControlCommunity taskforceH Fred Mickelson, USA (chair)Massimo Crespi, ItalyPetra Fordelmann, South AfricaAlena Petrakova, SwitzerlandEddie McCaffrey, UKMichael Eriksen, USAYuri Quintana, USAAna Lucia Ruggiero, USA

HPV and cervical cancer advisorygroupHarald zur Hausen (chair),GermanyChris JLM Meijer, the NetherlandsHélène Sancho-Garnier, FranceRengaswamy Sankaranarayanan,FranceAchim Schneider, GermanyMargaret Stanley, UKSuzanne Garland, AustraliaCarlos Santos, PeruJoe Harford, USAHarri Vertio, Finland

World Cancer Declaration steering groupFranco Cavalli (chair), SwitzerlandEduardo Cazap, ArgentinaDavid Hill, AustraliaThierry Philip, FranceKazuo Tajima, JapanAlberto Costa, Switzerland

GLOBALink advisory committeeLuk Joossens (chair), BelgiumYussuf Saloojee (vice chair), SouthAfricaDoreen McIntyre, UKPascal Diethelm, SwitzerlandPrakash Gupta, IndiaSimon Chapman, AustraliaStan Shatenstein, CanadaStella Aquinaga Bialous, USA

International cancer fellowshipsACSBI/ICRETT/YY project chairsselection taskforceDiane Robins (ACSBI chair), USANicol Keith (ICRETT chair), UKJohn Chester (ICRETT co-chair),UKCurzio Ruegg (YY chair),SwitzerlandJoe Harford, USAPaolo Boffetta, IARCAlberto Mantovani, ItalyMarie Chow, USAEvgeny Imyanitov, RussiaTetsuo Noda, JapanJohn Stevens, USA

Trish Greene cancer nursingworkshopsKristine B LeFebvre, USA

Fellowships reviewers(as of 13 December 2007)Clement Adebamowo, NigeriaKanchan Adhikari, NepalMª Eva Alonso, SpainArja Aro, DenmarkBaffour Awuah, GhanaPeter Barrett-Lee, UKLev Berstein, RussiaPeter Blake, UKCristina Bosetti, ItalyMichael Brada, UKDavid Brewster, UKNigil Bundred, UKM Saveria Campo, UKLynn Cawkwell, UKKentChu, ChinaStefano Ciatto, ItalyEmile Comans, the NetherlandsHarry Comber, UKLuca Cozzi, SwitzerlandBernard Cummings, CanadaJack Cuzick, UKEduardo De Stefani, UruguayShoukat Dedhar, CanadaSV Deo, IndiaAnders Ekbom, SwedenMostafa El-Haddad, EgyptJesme Fox, UKIan Frazer, AustraliaYu Tang Gao, ChinaBengt Glimelius, SwedenThomas Glynn, USAJames Going, UKAlan Grundy, UKNeva Haites, UKJanet Hall, FranceAndrias Hambardzumyan,ArmeniaMichel Henry-Amar, France

Steve Heys, UKD Jodrell, UKHarish Joshi, USAMalgorzata Karbownik, PolandReza Khodabakhshi, IranVeronika Kloboves Prevodnik,SloveniaUwe Koch, GermanyPasi Koivisto, FinlandNathan Krishnamurthy, IndiaAndrzej Kulakowski, PolandRakesh Kumar, IndiaAbraham Ruten, ItalyPagona Lagiou, USAEduardo Laura, ArgentinaJonathan Ledermann, UKSam Leinster, UKAnnika Lindblom, SwedenAntonio Llombart-Bosch, SpainMarc Mareel, BelgiumAlan McKay, UKK Metodiev, BulgariaWilliam Miller, UKHenrik Moller, UKLisa Morikawa, BrazilSue Moss, UKAnsusheel Munshi, IndiaJai Neema, IndiaJahn Nesland, NorwayRobert Newbold, UKVu Quoc Nguyen, VietnamJohn David Norton, UKIra Pavlovic-Ruzic, CroatiaElisabeth Petty, USALuis Pinillos Ashton, PeruMiriam Poirier, USARobert Ramsay, AustraliaPiere Rogalla, GermanyMarianne Rots, the NetherlandsP Sachdanandam, IndiaAzmat Sadozye, PakistanYogendra Sapru, IndiaWerner Scheithauer, AustriaFreddy Sitas, AustraliaR Stein, UKAnn Steyn, South AfricaKari Syrjanen, FinlandJoel Tepper, USAKurt Tournoy, BelgiumDimitrios Trichopoulos, USAHema Vaithianathan, AustraliaPaul Van Diest, the NetherlandsGalina Velikova, UKMarcel Verheij, the NetherlandsWeiguang Wang, UKEva Weiler-Mithoff, UKRichard Wooster, USAShu Zheng, ChinaPagona Lagiou, USAEduardo Laura, ArgentinaSam Leinster, UK


32

Peter Levendag, the NetherlandsAnnika Lindblom, SwedenAntonio Llombart-Bosch, SpainJ Loeffler, USALeendert Looijenga, theNetherlandsEugene.Lukanidin, DenmarkE Lundgren, SwedenAnne Lykkesfeldt, DenmarkFiona MacGregor, UKAsem Mansour, JordanAdam Marcus, USAMarc Mareel, BelgiumJoseph Maria Das, IndiaPhil Mason, USAAlan McKay, UKK Metodiev, BulgariaEnrico Mihich, USABernard Mijnheer, theNetherlandsWilliam Miller, UKHenrik Moller, UKLisa Morikawa, BrazilRandall Morton, New ZealandSue Moss, UKAnsusheel Munshi, IndiaJai Neema, IndiaJahn Nesland, NorwayRobert Newbold, UKVu Quoc Nguyen, VietnamJohn David Norton, UKRowan Parks, UKMarinus Paul, the NetherlandsIra Pavlovic-Ruzic, CroatiaMick Peake, UKRichard Peschel, USAGodefridus Peters, theNetherlandsBorislava Petrovic, SerbiaBogdan Petrunov, BulgariaElisabeth Petty, USADavid Phillips, UKLuis Pinillos Ashton, PeruMiriam Poirier, USADavid Quinn, USAK Rajewsky, USAManfred Rajewsky, GermanyRobert Ramsay, AustraliaBeate Rau, GermanyRoger Reddel, AustraliaOlle Ringden, SwedenPiere Rogalla, GermanyCarlo Rossi, ItalyMarianne Rots, the NetherlandsP Sachdanandam, IndiaAzmat Sadozye, PakistanYussuf Saloojee, South AfricaYogendra Sapru, IndiaAndreas Schätzlein, UKPhilip Schein, USAWerner Scheithauer, AustriaRik Scheper, the NetherlandsRaymond Schiffelers, theNetherlandsWolfgang Schlegel, GermanyReinhard Schwartz-Albiez,Germany

Evelyne Segal-Bendirdjian, FranceJavad Shahidi, CanadaPeter Sharp, UKBen-Zion Shilo, IsraelFreddy Sitas, AustraliaDavid Soutar, UKValérie Speirs, UKEric Stanbridge, USAR Stein, UKBo Stenerlow, SwedenAnn Steyn, South AfricaGuy Storme, BelgiumIan Stratford, UKRobert Stuart, UKBrindha Subramanian, AustraliaRobert Sudderick, UKShi-Yong Sun, USAChrister Sundstrom, SwedenAndrew Sykes, UKKari Syrjanen, FinlandJoel Tepper, USABruce Thomadsen, USAKurt Tournoy, BelgiumG Tozer, UKDimitrios Trichopoulos, USAHema Vaithianathan, AustraliaMartin Van den Bent, theNetherlandsPaul Van Diest, the NetherlandsJP van Meerbeeck, BelgiumHendrik Van Poppel, BelgiumGerard van Rhoon, theNetherlandsPaul Van Schil, BelgiumGeorges Vassaux, FranceAnjo Veerman, the NetherlandsGalina Velikova, UKMarcel Verheij, the NetherlandsRHM Verheijen, the NetherlandsJaap Verweij, The NetherandsStefaan Vynckier, BelgiumHaakan Wallin, DenmarkWeiguang Wang, UKRoger Watson, UKSteve Webb, UKEva Weiler-Mithoff, UKMary Weiss, FranceJochen Werner, GermanySiu-Fun Wong, USARichard Wooster, USAWei Xiao, CanadaIlana Yron, IsraelNadia Zaffaroni, ItalyShu Zheng, ChinaJingde Zhu, ChinaA Gianella, USALU Krebs, USAElizabeth Owens, USAEmily Ang, SingaporeSabine Perrier-Bonnet, FranceVirginia LeBaron USAJulia Mercedes Challinor, USASarah Hope Kagan, USAMary Schwarz McCabe, USANancy E Kline, USANessa Coyle, USAErika Maria Monteiro Santos, Brazil

A Barsevick, USANancy Houlihan, USAMyrna McLaughlin Anderson,PanamaWinnie So, ChinaEunyoung Suh, KoreaMeera Achrekar, IndiaGay Frances Bailey, USAElizabeth Rodriguez, USA

TNM core committee Leslie Sobin, USAUmed Ajani, USAHisao Asamura, JapanJames Brierley, CanadaLouis Jean Denis, BelgiumMary Gospodarowicz, CanadaJoe Harford, USAFrederick Greene, USAPatti Groome, CanadaMalcolm Mason, UKBrian O'Sullivan, CanadaSergio Pecorelli, ItalyChristian Wittekind, Germany

TNM processMary Gospodarowicz, CanadaUmed Ajani, USAFrederick Greene, USAPatti Groome, CanadaSergio Pecorelli, ItalyLeslie Sobin, USA

TNM expert panelBreastJohn Boyages, AustraliaStephen B Edge, USAIan Ellis, UKPatrick L Fitzgibbons, USADaniel F Hayes, USAKathleen Pritchard, CanadaEva Sonja Singletary, USA

Upper gastrointestinal Norman Carr, AustraliaBernard Cummings, CanadaPhillip Johnson, UKGünter Klöeppel, GermanyJohn Primrose, UKTadakazu Shimoda, JapanChristian Wittekind, Germany

Lower gastrointestinal Norman Carr, AustraliaCarolyn Compton, CanadaBernard Cummings, CanadaJ Milburn Jessup, USAJan Wilhelm Leer, the NetherlandsChristian Wittekind, Germany

Genitourinary Hideyuki Akaza, JapanFernando Algaba, SpainGeorg Bartsch, AustriaDavid Dearnaley, UKLouis Jean Denis, BelgiumZiya Kirkali, Turkey

James Montie, USAAlan Pollack, USAMack Roach III, USACora Sternberg, ItalyIan Thompson, USA

Gynaecological William J Creasman, USAWilliam J Hoskins, USAAnthony Fyles, CanadaStanley Kaye, UKMaurie Markman, USAHextan Ngan, ChinaSergio Pecorelli, Italy

Head and Neck (TNHN) E Leon Barnes, USAJohn K C Chan, ChinaVincent Chong, SingaporeSteve Hall, CanadaPeter Rhys-Evans, UKAnn Lee, ChinaSuresh Mukherji, USABrian O'Sullivan, CanadaJatin Shah, USA

LungDavid Ball, AustraliaElisabeth Brambilla, FranceMichael Brundage, CanadaPeter Goldstraw, UKThierry Le Chevalier, UKNed Patz, USAWilliam Travis, USA

LymphomaJames Armitage, USARichard Hoppe, USAAlan Horwich, UKAndrew Lister, UKPeter Mauch, USALena Specht, DenmarkAndrew Wirth, AustraliaEmanuele Zucca, Switzerland

Sarcoma/boneRobert S Bell, CanadaPeter Choong, AustraliaCyril Fisher, UKIan Judson, UKBrian O'Sullivan, CanadaPeter Pisters, USARaphael E Pollock, USAMartin Robinson, UKMatt van de Rijn, USAJaap Verweij, the Netherlands

SkinNatale Cascinelli, ItalyDavid Elder, USAPeter Heenan, AustraliaPhilip E LeBoit, USAMartin Mihm, USAGeorge Murphy, USAMichael G Poulsen, AustraliaJohn F Thompson, AustraliaRichard Tsang, Canada


Com

mitt

ees

and

task

forc

es

33

TNM prognostic factors taskforce Mary Gospodarowicz, CanadaUmed Ajani, USACarolyn Compton, USAFrederick Greene, USAPatti Groome, CanadaMalcolm Mason, UKBrian O'Sullivan, CanadaLeslie Sobin, USAChristian Wittekind, Germany

TNM Atlas editorial taskforceLeslie Sobin, USAFrederick Greene, USAChristian Wittekind, Germany

TNM Supplement editorial group Leslie Sobin, USAChristian Wittekind, Germany

Needs assessments of cancerpatient groups in eastern Europepilot projectJeff Dunn, AustraliaPatricia Allen, SwitzerlandAngela Grezet-Bento deCarvalho, SwitzerlandSilvana Hertz, SwitzerlandTezer Kutluk, TurkeyThea Marais, SwitzerlandCharles-Henri Rapin, SwitzerlandMichael Hathorn, Switzerland

“Today’s children, tomorrow’sworld” global survey on cancerprevention and risk reductiontechnical advisory taskforceMelanie Wakefield (chair),AustraliaHein de Vries, the NetherlandsMike Stefanek, USASharon Campbell, CanadaJane Wardle, UK

“I love my smokefree childhoodcampaign” advisory committeeYumiko Mochizuki (chair), JapanArmando Peruga, WHOSylvianne Ratte, FranceYussuf Saloojee, South AfricaJonathan Samet, USAMichael Thun, USAWitold Zatonsky, PolandAlex Prokhorov, USA

“My child matters” advisorysteering committeeFranco Cavalli (chair), SwitzerlandAndrea Biondi, USATim Eden, UKJoe Harford, USAJean Lemerle, FranceIan Magrath, BelgiumRaul Ribeiro, USAHélène Sancho-Garnier, FranceEva Steliarova-Foucher, FranceGeoff Thaxter, UK

Allen Yeoh, SingaporeIsabelle Tabah-Fisch, FranceCaty Forget, France

BloomAnn Steyn (editor-in-chief)Jeff Dunn, AustraliaRanjit Kaur, MalaysiaIngrid Cox-Lockhart, consultantIsabel Mortara, UICCSilvia Perel, UICCPáraic Réamonn, UICCAnna-Maria Vandelli, UICC

Global News Alert editorial advisory boardPaola Pisani, UK (managing editor)Dawn Antoline, USA (editor)Marc Bollet, FranceEduardo Cazap, ArgentinaMassimo Crespi, ItalyPhilip Davies, FranceJeff Dunn, AustraliaMichael P Eriksen, USALeticia Fernandez, CubaJanet Hall, FranceAnton GJM Hanselaar, theNetherlandsJoe Harford, USADavid Hill, AustraliaEng-Siew Koh, CanadaTezer Kutluk, TurkeyDavid Lane, UKJane Maher, UKHugo Marsiglia, FranceIgnacio Miguel Musé, UruguayBrian O'Sullivan, CanadaUgo Pastorino, ItalyEbert Poquioma, PeruLisseth Ruiz de Campos, ElSalvadorGraciela Sabini, UruguayHélène Sancho-Garnier, FranceCarlos Santos, PeruGustavo Sarria, PeruPeter Sasieni, UKCraig Sinclair, AustraliaAnn Steyn, South AfricaKazuo Tajima, JapanAnne Vezina, CanadaMaggie Watson, UK

International Journal of CancerHarald zur Hausen (editor-in-chief), Germany

Associate editorsHelmut Bartsch, GermanyNorbert Fusenig, GermanyKari Hemminki, GermanyMagnus von Knebel Doeberitz,GermanyBruno Kyewski, GermanyPeter Lichter, Germany

Editorial boardStuart Aaronson, USABharat Aggarwal, USABruce Armstrong, AustraliaGraham Baldwin, AustraliaMariano Barbacid, SpainWalter Birchmeier, GermanyMina Bissell, USAMikhail Blagosklonny, USAC Richard Boland, USAThierry Boon, BelgiumElisabeth Brambilla, FranceMax Burger, SwitzerlandJudith Campisi, USAWebster Cavenee, USAPaolo Comoglio, ItalyPelayo Correa, USAJack Cuzick, UKAlbert de la Chapelle, USADylan Edwards, UKManel Esteller, SpainJohn Field, UKJudah Folkman, USAAdi Gazdar, USAMartin Glennie, UKDavid Goldgar, FranceNorman Greenberg, USACarol Greider, USAWilliam Grizzle, USAUlf Gyllensten, SwedenMasanori Hatakeyama, JapanCarl-Hendrik Heldin, SwedenMeenhard Herlyn, USAJames Herman, USARoland Herrero, Costa RicaEric Holland, USAMonica Hollstein, GermanyWaun-Ki Hong, USARuth Jarrett, UKAlexander Knuth, SwitzerlandRalf Küppers, GermanyCarlo La Vecchia, ItalyGilbert Lenoir, FranceDouglas Lowy, USADavid Malkin, CanadaAlberto Mantovani, ItalyChris Meijer, the NetherlandsCJM Melief, the NetherlandsPaul Meltzer, USAAnthony Miller, CanadaKohei Miyazono, JapanPatrick Moore, USAKarl Munger, USASteven Narod, CanadaRob Newbold, UKHiroshi Ohshima, FranceMehmet Ozturk, TurkeyJae-Gahb Park, KoreaDonald Maxwell, UKManuel Perucho, USABruce Ponder, UKRanju Ralhan, IndiaGuido Reifenberger, GermanyPedro Romero, SwitzerlandHélène Sancho-Garnier, FranceGuido Sauter, GermanyKeerti Shah, USA

Michael Stratton, UKTadatsugu Taniguch, JapanIan Tomlinson, UKAlexander Varshavsky, USAPaolo Vineis, UKChristopher Wild, UK

Manual of Clinical OncologyRaphael Pollock (editor), USA

Associate editorsJames Doroshow, USADavid Khayat, FranceAkimasa Nakao, JapanBrian O’Sullivan, UK

Awards for excellence in cancer control 2008Eduardo Cazap (chair), ArgentinaBruno Meili, SwitzerlandClaire Neal, USAPaul Ndom, CameroonXi-shan Hao, China


34

Algeria ICR Kenida, SaidArgentina YY Diaz, Maria del Pilar

ICR Girotti, MariaICR Pelisch, FedericoTCS Sebrie, Ernesto

Armenia ICR Hovhannisyan, RubenAustralia YY Clyne, Colin Douglas

ICR Gan, Pei PeiICR Jones, Mathew

Belarus ICR Serhiyenka, TatsianaBrazil ICR De Oliveira Meireles da Costa,

NathaliaICR Silva, MarcusICR Werner, Betina

Bulgaria ICR Georgieva, MilkaCameroon ICR Ikomey, GeorgeCanada ICR Hanna, Timothy

ICR Page, MichelChile TCS Castillo, Rosario

ICR Torrente, MarielaChina ICR Cao, Junning

ICR Chen, JinfengICR Ling, HongICR Yu, Lei

Colombia ICR Rodriguez Garcia, JosefaCroatia ICR Ibrahimpasic, TihanaCuba ICR Alvarez Guerra, Sandra

ICR Cedeño Arias, MercedesICRR Fernandez Garrote, LeticiaICR Fors, MarthaICR Garcia Verdecia, BeatrizICR Menendez Alejo, IbisICR Montenegro, AlexanderICR Rodriguez Nunez, OlgaICR Roque Navarro, LourdesICR Tejuca Martinez, Mayra

Cyprus ICRR Komodiki, CharitiniCzech Republic ICR Knizetova, PetraEgypt ICR Abd Al-Moez Ramadan, Mostafa

ICR Ahmad, MohamedICR Ellabban, MohamedICR Ismail, Emam

TCS Labib, NargisICR Nazmy, MohamedICR Shouman, Tarek

Estonia ICR Nelis, MariFrance YY Feunteun, Jean

ICR Metellus, PhilippeGeorgia ICR Kartvelishvili, NinoGermany YY Klein, Christoph

ICR Seliger, BarbaraGuatemala TCS Oliva Pozuelos, DoraIndia ICR Abraham, Deepak

ICR Abraham, ElizabethICR Agrawal, SushmaICRR Balakrishnan, RajanAPC Bapat, AditiACS Basu, SandipICR Bose, SudhakarICR Chatterjee, IndranilICR Deb, PrabalICR Dubey, DeepakICR Ganesan, PadmaYY Gangane, NitinICR Haniball, JikkuICRR Jagadeesan, MarimuthuICR Jheeta, KuldeepICR Kalra, NaveenICR Kishore, SomanathanICR Krishnamurthy, NathanICR Krishnan Nair, Chandra MohanICRR Kumar, AlokICR Mishra, Deepak KumarAPC More, NeetaICR Munjal, KavitaICR Mynampati, DineshICR Narang, SubinaICR Narayanan, KannanICR Odedra, ParbatICR Patel, AartiICRR Pati, UttamICR Pelagade, SatishkumarICR Pillai, SreekumarTCR Ralhan, Ranju

International Cancer Fellowsin 2007Country Scheme Country Scheme


Inte

rnat

iona

l can

cer

fello

ws

in 2

007

35

ICR Ramanathapuram Venkatasubramaniam, Parameswaran

APC Rangarajan, VijayaYY Sengupta, SuparnaICR Shanti, ParasuramICR Sharma, DayaAPC Sharma, RajICR Singh, AvninderICR Singh, BhuvneshICR Sreekumar, C.ICR Srinivasan, KarthikeyanICR Surendran, NatarajanICR Thakar, Alok

Indonesia TCS Soerojo, WidyastutiIran ICR Entezari, Vahid

ICR Haddad, PeimanIsrael YY Ast, Gil

ICR Pichinuk, EdwardItaly YY Lupi, Monica

YY Molinaro, EleonoraICR Piccin, DanielaICR Rossi, MartaICR Sgura, Antonella

Jordan ICR Abdullah, SameerICR Alzaben, Abdulhadi IsmailICR Samer, Al-Geizawi

Kenya TCS Kitonyo, RachelLithuania TCS Veryga, AurelijusMalaysia TCS Tan, Yen LianMoldova TCS Tataru, VictoriaNepal APC Mainali, Ram Nath

APC Pariyar, SitaICR Regmi, SurendraICR Sapkota, ShivaICR Thakur, Binay

Netherlands ICR Borst, GerbenICR Castermans, KarolienICR Van der Gun, Bernardina

Nigeria ICR Abdulkareem, FatimahICR Adewole, OlanisunICR Aniagwu, Toyin Ibironke GraceTCS Ogbara, NurudeenICR Olusina, DanielTCS Oyegbile, OlayinkaICR Titiloye, Nicholas

Pakistan ICR Rashid, MuhammadICR Sabih, ZahidaTCS Zehra, Kaneez

Peru ICR Rios, PedroPhilippines TCS Trinidad, FlorantePoland ICR Kepka, Lucyna

YY Poplawski, TomaszICR Zolnierowicz, Joanna

Romania ICR Lotrean, Lucia MariaICR Neghina, Adriana-Maria

Russia ICR Aushev, VasiliyICR Iyevleva, Aglaya

Serbia & Montenegro ICR Panjkovic, MilanaSingapore ICR Villegas, MariflorSlovakia ICR Cipak, LubosSouth Africa ICR Wessels, GlynnSweden ICR Rennstam, Karin

YY Sangfelt, OlleSwitzerland ACS Riesterer, OliverTanzania TCS Kagaruki, LutgardThailand ICR Attasara, Pattarawin

TCS Charoenca, NaowarutTurkey YY Akbulut, Hakan

ICR Alimoglu, EmelICRR Deniz, GunnurICR Satiroglu-Tufan, N. Lale

Uganda ICRR Sewankambo, NelsonTCS Tumwine, Jaqueline

Ukraine ICR Gryshkova, VitalinaICR Malanchuk, Oksana

UK ICR Smith, KevinICR Stephens, Nathan

USA ICR Rabi, ThangaiyanICR Yuan, ZiICR Stanbridge, Eric

Venezuela ICR Suárez Hurtado, BennyVietnam ICR Bui Duc, Tung

ICR Nguyen, Dieu LinhICR Nguyen, Van Thanh

ACS American Cancer Society international fellowship for beginning investigators

APC Asia-Pacific cancer society training grantICR International cancer technology transfer

fellowshipICRR ICRETT training workshopYY Yamagiwa-Yoshida Memorial international

cancer study grant

Country Scheme Country Scheme

Financial report 2007Report of the treasurer

The International Unionagainst Cancer (UICC)records its income and

expenditure in two distinct accounts.Unrestricted funds relate primarily tothe operations of the UICC secre-tariat and are accounted in Swissfrancs. Restricted funds are designat-ed for specific UICC programmes

and are expressed in US dollars. Forreporting purposes, the two sets ofaccounts are consolidated into onecombined financial statementexpressed in US dollars.

The 2007 financial statements wereaudited by PricewaterhouseCoopersSA, who are satisfied that theaccounting records comply withSwiss law and UICC’s statutes andbye-laws and recommend that thefinancial statements be approved (seepage 38).

IncomeTotal unrestricted and restricted

income in 2007 amounted toUS$8,356,566, compared withUS$7,721,190 in 2006.

Unrestricted income, whichmainly covers the operations of theUICC secretariat, amounted toUS$2,421,491. Unrestricted duesand contributions received fromUICC member organizationsdeclined by approximately 20% fromthe previous year to US$900,080 but

remained the single most importantunrestricted contribution to revenue.Following the modification of theconcept of national subscriptions,some members reallocated their vol-untary contributions to the newlyestablished Solidarity Fund and des-ignated programmes. During thereporting year, 15 organizations ter-minated their membership and 25organizations joined UICC. At theend of 2007, membership stood at286 organizations across 93 coun-tries.

Thanks to the acquisition of sever-al new corporate partners, incomefrom corporate partners increasedconsiderably to US$335,855 and hasbecome an additional importantsource of unrestricted income.

Publications income received byUICC amounted to US$763,460 andderives primarily from royaltiesreceived from John Wiley and Sons(now Wiley-Blackwell), the publish-er of UICC's International Journal ofCancer.

Dr Mary GospodarowiczTreasurer and chair of the finance committee

2007 TOTAL INCOME

63%16%

17%4%

Contributions, Contracts & FeesMembers & Partners IncomePublicationsOther

2007 TOTAL EXPENDITURE

53%

5%11%

31%

Projects & InitiativesUICC CongressesPublicationsOperating Costs


36


In 2007 UICC also benefited froma final payment of US$250,000 fromthe American Cancer Society as thelocal organizer of the World CancerCongress 2006.

Restricted income, which is des-ignated for specific programmes andactivities, increased considerablyfrom 2006 to US$5,935,075. Theincrease in income was primarily dueto funds secured for the WorldCancer Congress 2008 and theWorld Cancer Campaign and fundsreceived for the newly establishedcapacity-building fund (US$178,057)and solidarity fund (US$76,943).

In 2007, UICC received contribu-tions from over 40 donors aroundthe world in support of its differentprojects.

ExpenditureTotal unrestricted and restricted

expenditure in 2007 amounted toUS$6,651,852, by comparison withUS$7,618,716 in 2006.

Unrestricted expenditure relatedto UICC's operating costs declinedmoderately, from US$2,409,202 in2006 to US$2,309,292. During thereporting year there were no partic-ular one-off events requiring addi-tional expenditure, and costs couldbe kept well within the annual budg-et.

The unrestricted accounts for theyear show a net surplus ofUS$112,198, which means thatUICC was able to save a portion ofthe unrestricted income received in2007 as a reserve for its operations in2008.

Restricted expenditure for pro-grammes and publications amountedto US$4,342,559, by comparisonwith US$5,209,513 in 2006.

As the restricted funds are account-ed for on a cash basis there can besignificant differences in a given yearbetween funds received for designat-ed projects and funds disbursed.Some programmes carried forwardcash balances from 2006 that con-tributed to covering expenditureincurred in 2007.

Fund balances and reservesThanks to net savings in the unre-

stricted accounts, the unrestrictedfree fund balance increased moder-ately to US$1,130,575 at the end of2007. This also included an alloca-tion of US$50,000 to the statutoryreserves, which stood at US$300,000at year end.

The fund balances for the restrict-ed accounts reflected the increase inthe income received for activitiesthat are still in process (for example,the World Cancer Congress 2010and the World Cancer Campaign).Accordingly the restricted fund bal-ances increased significantly andstood at US$3,792,608 at year end.

The finance committee met regu-larly during 2007 to ensure, togetherwith the treasurer, that UICC'sfinances are effectively used andmanaged.

We thank all UICC memberorganizations for their loyal support.It is essential for UICC to continueto receive generous financial supportfrom its members, in excess of thestatutory annual dues, to ensure a sta-ble organizational future and carryforward its strategic activities.

We also take this opportunity toexpress our gratitude to all ourdonors and supporters (see page 40),without whom UICC could notcarry out its work.

The International UnionAgainst Cancer (UICC) is aninternational, non-govern-mental organization governedin accordance with articles 60to 79 of the Swiss civil code.Its objective is to advancescientific and medical know-ledge in research, diagnosis,therapy, and prevention ofcancer and to promote allother aspects of the campaignagainst cancer throughout theworld. Its headquarters are inGeneva, Switzerland.

As a non-profit organizationdevoted to the public interest,UICC has been exemptedfrom income tax by the Swisstax authorities. UICC's annualbudget is supported by mem-bership dues, royalties frompublications, and restrictedand unrestricted grants anddonations from cancer socie-ties, foundations, governmentagencies, corporations andindividuals.

UICC is governed by its mem-ber organizations, which meetevery two years in a generalassembly, held in conjunctionwith the World CancerCongress. Between assem-blies, UICC is governed by aboard of directors elected bythe general assembly, which isresponsible for programmestructure and implementation.

To support our work, visit theUICC website (www.uicc.org).

Tax status

Fina

ncia

l rep

ort

37


38


Income and expenditure in US Dollars

Fina

ncia

l rep

ort

The figures presented on thispage are a summary of thefinancial statements of UICC.A complete set of the auditedfinancial statements for 2007,including accompanying notes,may be obtained on requestfrom the secretariat in Geneva.

39

2007 2006Unrestricted Restricted Total Unrestricted Restricted Total

IncomeContributions, Contracts & Fees (272,656) (4,948,668) (5,221,324) (480,489) (4,255,853) (4,736,342)Membership dues (900,080) (132,007) (1,032,088) (1,130,116) (1,130,116)Corporate Partnerships (335,856) (335,856) (206,275) (206,275)Publications (770,784) (650,878) (1,421,662) (858,509) (540,885) (1,399,394)Others (142,115) (203,522) (345,638) (124,651) (124,412) (249,064)

TOTAL INCOME (2,421,491) (5,935,076) (8,356,567) (2,800,040) (4,921,150) (7,721,190)

ExpenditureProjects and initiatives 211,970 3,265,451 3,477,421 251,883 4,528,120 4,780,003UICC congresses 0 329,619 329,619 177,326 41,179 218,506Publications 10,060 747,490 757,550 9,123 640,215 649,337Operating costs 2,087,263 0 2,087,263 1,970,870 0 1,970,870

TOTAL EXPENDITURE 2,309,292 4,342,560 6,651,852 2,409,203 5,209,514 7,618,716

Income (over) under expenditure (112,199) (1,592,516) (1,704,715) (390,837) 288,363 (102,474)

Fund balances, beginning of year (1,068,377) (2,200,091) (3,268,468) (727,540) (2,488,454) (3,215,994)Allocation to statutory reserve 50,000 0 50,000 50,000 50,000Fund balances, end of year (1,130,575) (3,792,607) (4,923,182) (1,068,377) (2,200,091) (3,268,468)

2007 2006ASSETSCurrent accounts 661,078 186,464Time deposits 4,131,543 2,725,781Membership dues, net 12,511 28,600Related parties 42,023 23,732Other receivable 200,353 80,073Prepaid expenses 10,159 5,274Total current assets 5,057,667 3,049,924

Financial investments 750,000 750,000Fixed assets, net 59,216 44,598Total non current assets 809,216 794,598

TOTAL 5,866,883 3,844,522

LIABILITIES 2007 2006Accounts payable & accrued expenses 307,651 194,695Reserve for restricted currencies 16,293 14,267Other liabilities 17,915 37,927Total current liabilities 341,859 246,889

Fund balance - unrestricted 1,130,575 1,068,376Statutory reserve - unrestricted 300,000 250,000Trust funds - restricted 3,792,608 2,200,091Translation difference 301,841 78,066Total fund balances 5,223,183 3,518,467

TOTAL 5,866,883 3,843,422

Balance sheet at 31 December in US Dollars

40


American Cancer Society . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .819,001Pfizer Global Health Partnerships, USA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .535,000Centres for Disease Control & Prevention, USA . . . . . . . . . . . . . . . . . . . . . . . . . .371,499Cancer Research UK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .278,755Merck & Co, USA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .275,000MDS, Canada . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .273,251National Cancer Institute, USA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .225,000UICC International Cancer Foundation, Switzerland . . . . . . . . . . . . . . . . . . . . . . .196,721John Wiley & Sons, USA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .195,000Bristol-Myers Squibb, USA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .189,470Novartis, Switzerland . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .186,568Japan National Committee for UICC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .150,000Swedish Cancer Society . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .102,733Pfizer, USA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .85,000Ajahma Charitable Trust, UK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .78,547GlaxoSmithKline, UK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .110,000European Community . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .73,650Sanofi-aventis, France . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .68,372Deutsche Krebshilfe, Germany . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .60,000Susan G Komen for the Cure, USA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .50,000Bill and Melinda Gates Foundation, USA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .49,705Ligue nationale contre le cancer, France . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .46,142Furana Foundation, Liechtenstein . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .40,984Digene, Switzerland . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .40,000Johnson & Johnson, USA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .30,800American Society of Clinical Oncology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .30,000Oncology Nursing Society, USA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .30,000Swiss Cancer League . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .30,000National Cancer Institute, Canada . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .28,000Eli Lilly, USA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .27,149Dutch Cancer Society . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .27,032Cancer Council Australia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .22,200Associazione Italiana per la Ricerca sul Cancro, Italy . . . . . . . . . . . . . . . . . . . . . . . .18,000Heng Rui Pharmaceuticals, China . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .17,000Israel Cancer Association . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .14,000Danish Cancer Society . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .11,000Cancer Society of Finland . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .6,833

World Cancer Congress 2008Federal Office of Public Health, Switzerland . . . . . . . . . . . . . . . . . . . . . . . . . . . . .122,951Oncosuisse, Switzerland . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .81,967Swiss Cancer League . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .81,967European School of Oncology, Italy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .80,956Other congress contributions and income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .394,270

Cancer capacity-building fund . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .178,058Solidarity fund . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .76,943Sundry contributions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .2,656

RoyaltiesInternational Journal of Cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .763,460Other publications . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .7,324

Contributors 2007US dollars

Corporate partners make an annual unrestricted contribution in supportof UICC. Corporate partnership is open to leaders of the medical supplyand technology, pharmaceutical, biotechnology and health publishingindustries and other private sector companies.

Novartis Oncology

Eli Lilly

Sanofi-aventis

Heng Rui Pharmaceuticals

John Wiley & Sons

Merck

GlaxoSmithKline Oncology

Corporate partners 2007

MDS

UICC is the leading international non-governmental organization dedicated exclusively to the global control of cancer.Its vision is of a world where cancer is eliminated as a major life-threatening disease for future generations.

resource for actionvoice for change

International Union Against Cancer (UICC)62 route de Frontenex • 1207 Geneva • SwitzerlandTel +41 22 809 18 11 • Fax +41 22 809 18 10 • [email protected] • wwww.uicc.org

Uniting to defeat cancerAnnual Report 2007

Documents

UICC Annual Report 2007: Uniting to defeat cancer